Document:

Second Amendment to Development Agreement

 Exhibit 10.68 
 *** Text Omitted and Filed Separately 
 Confidential Treatment Requested 

Under 17 C.F.R. §§ 200.80(b)(4) 
 and 240.24b-2 
 SECOND AMENDMENT TO DEVELOPMENT AGREEMENT 

This Second Amendment to Development Agreement (this “Second Amendment”) is entered into as of July 18, 2011 (the
“Amendment Effective Date”) by and between Applied Micro Circuits Corporation, a Delaware corporation having a place of business at 215 Moffett Park Drive, Sunnyvale, CA 94089 (“APM”), and Veloce Technologies, Inc.,
a Delaware corporation having a place of business at 2953 Bunker Hill Lane, Suite 300, Santa Clara, CA 95054 (“Company”). As used herein, APM and Company are referred to herein individually as a “Party” and
collectively, as the “Parties.” Capitalized terms not otherwise defined herein shall have the meanings ascribed to such terms in the Prior Development Agreement (as defined below). 

Background 
 WHEREAS, effective May 17, 2009 (the “Agreement Date”), each of (i) APM and Company entered into that certain Development Agreement, pursuant to which,
among other things, the Company agreed to develop exclusively for APM certain processors that meet certain specifications provided therein and the Merger Agreement (defined below), for inclusion in certain integrated circuits having other structures
designed by APM, which was subsequently amended effective November 8, 2010 by that certain First Amendment to Development Agreement (collectively, the “Prior Development Agreement”) (ii) APM, the Company, Espresso
Acquisition Corporation, a Delaware corporation and a wholly-owned subsidiary of APM (“Merger Sub”), and the other parties named therein, entered into that certain Agreement and Plan of Merger (as amended to date, the
“Merger Agreement”) pursuant to which Merger Sub shall be merged with and into Company, the separate existence of Merger Sub shall cease and Company will continue as the surviving corporation in the merger and shall continue its
existence under the laws of the State of Delaware, subject to the conditions and in accordance with the terms provided therein (the “Merger”), and (iii) APM, Company, the securityholders of Company and the other parties
named therein, entered into that certain Securityholder Agreement (as amended to date, the “Securityholder Agreement”), pursuant to which, among other things, such securityholders agree to certain voting provisions with
respect to their shares of Company Common Stock, and certain restrictions on the transferability thereof, and Company agreed not to issue additional equity interests in Company except in accordance with the terms of such agreement; and 

WHEREAS, the Parties have acknowledged and agreed that it is in the best interests of APM and Company to modify the
Prior Development Agreement to provide Company with additional financing in the aggregate amount of $2,000,000 (the “Additional Financing”) for use in connection with the Project, [...***...]; and 

WHEREAS, the Additional Financing shall be paid by APM to Company in the amounts set forth below: 

 

					
	 Amendment Effective Date:
	  	$	1,125,000	  
	 Quarter Starting October 1, 2011
	  	$	375,000	  
	 Quarter Starting January 1, 2012
	  	$	250,000	  
	 Quarter Starting April 1, 2012
	  	$	250,000	  

  

VELOCE TECHNOLOGIES, INC. 

SECOND AMENDMENT TO DEVELOPMENT AGREEMENT 

1 

 *** Text Omitted and Filed Separately 

Confidential Treatment Requested 
 Under 17 C.F.R. §§ 200.80(b)(4) 
 and 240.24b-2 

 

 WHEREAS, the Parties have acknowledged and agreed that no
adjustment shall be made to the consideration payable by APM at the closing of the Merger pursuant to the Merger Agreement on account of such Additional Financing: 
 NOW, THEREFORE, in consideration of the premises and other good and valuable consideration received and to be received by the Parties hereunder, the
Merger Agreement and Securityholder Agreement, the Parties agree to the following: 
 Agreement 

 

	1.	PAYMENT 

The sections of the Prior Development Agreement pertaining to quarterly payments (for the avoidance of doubt, Section 3.3 of the Development
Agreement dated as of May 17, 2009 and Section 2.1 of the First Amendment to Development Agreement dated as of November 8, 2010) is hereby amended and restated in its entirely to read: 

1.1 Quarterly Payments. From and after the Amendment Effective Date, in consideration for Company’s performance of the
Project as modified pursuant to this Second Amendment, during the term of this Agreement, APM will pay Company up to the full quarterly payment (each, a “Quarterly Payment”), for up to nine (9) consecutive calendar quarters
(each a “Calendar Quarter”) (or portions thereof), commencing with the Calendar Quarter in which this Second Amendment is entered into (the “Quarterly Payment Period”), subject to such shorter period provided under
Section 9 of the Prior Development Agreement (including without limitation under Section 9.4.2 thereof in the event of a Good Faith Allegation of Breach (as defined in such Section 9.4.2)), provided that APM may deduct from
each Quarterly Payment for a Calendar Quarter any rent APM pays for the Facility pursuant to the Lease with respect to such Calendar Quarter and with respect to any prior Calendar Quarter that was not deducted from a Quarterly Payment. With respect
to the Calendar Quarter commencing October 1, 2011, the Quarterly Payment hereunder shall be an amount equal to $2.625 Million. With respect to each of the Calendar Quarters commencing January 1, 2012 and April 1, 2012, the Quarterly
Payment hereunder shall be an amount equal to $2.5 Million. From and after the Calendar Quarter commencing July 1, 2012, the Quarterly Payments hereunder shall be an amount equal to $2.25 Million. Each Quarterly Payment shall be made not later
than ten (10) days following beginning of the applicable Calendar Quarter. A Calendar Quarter begins on January 1st, April 1st, July 1st, and October 1st of each applicable year. 

1.2 One-Time Payment. Substantially concurrently with the execution of this Amendment, APM shall pay to Company a one-time payment
in the amount of $1.125 million in connection with (i) [...***...] and (ii) Company’s increased expenses associated with the Project [...***...]. 
 1.3 Prepayments. APM shall have the right (upon a request by Company), but not the obligation (except that APM shall not unreasonably refuse such a request), to pay Company an amount above each
such Quarterly Payment in order to assist Company in meeting expenses to perform its obligations under this Agreement, provided that the total of all amounts paid by APM 

  

VELOCE TECHNOLOGIES, INC. 

SECOND AMENDMENT TO DEVELOPMENT AGREEMENT 

2 

 *** Text Omitted and Filed Separately 

Confidential Treatment Requested 
 Under 17 C.F.R. §§ 200.80(b)(4) 
 and 240.24b-2 

 

 
to Company pursuant to this sentence (collectively, the “Prepayment”) shall be deducted from the consideration payable by APM at the closing of the Merger pursuant to the Merger
Agreement. Each increase in Company expenses that is likely to lead to a request for a Prepayment shall be approved in advance by the Board of Directors of Company and, in the event of any such increase that exceeds $100,000 in a given quarter,
Company shall provide advance written notice to the Chief Financial Officer of APM; provided that any such approvals and notices may explicitly provide for multiple Prepayments over multiple quarters and, in such event, a single approval or notice
shall be sufficient to meet Company’s obligations hereunder. For all periods prior to the date of this Second Amendment, the terms and conditions of Section 3 of the Prior Development Agreement shall continue to govern and control.

  

	2.	REPRESENTATIONS AND WARRANTIES 

2.1 Representations, Warranties and Covenants of APM. APM represents and warrants to Company that each of the representations and
warranties set forth in Section 7.1 of the Prior Development Agreement are true and correct in all respects as of the Amendment Effective Date. APM will continue to perform each its covenants set forth in Section 7.1 thereof from and after
the Amendment Effective Date and for the duration of the Project and in accordance with the terms of the Prior Development Agreement, as amended to date. APM acknowledges and agrees that as of the date hereof, APM is not and shall not be entitled to
deduct any amounts from the consideration payable by APM at the closing of the Merger pursuant to the Merger Agreement based upon (i) the funding provided by APM to Company to date, or (ii) the funding provided for in Section 1.1 and
Section 1.2 hereof. 
 2.2 Representations, Warranties and Covenants of Company. Company represents and warrants to
APM that each of the representations and warranties set forth in Section 7.2 of the Prior Development Agreement are true and correct in all respects as of the Amendment Effective Date. APM will continue to perform each its covenants set forth
in Section 7.2 thereof from and after the Amendment Effective Date and for the duration of the Project. 
  

	3.	TERM AND TERMINATION 

3.1 Good Faith Allegation of Breach. Effective from and after the Amendment Date and expiring June 30, 2012,
Section 9.4.2 of the Prior Development Agreement is hereby amended to increase from $2.25 Million to $2.5 Million the amount of each periodic payment by APM to Company payable during the pendency of a Good Faith Allegation of Breach. Following
such expiration date, the amount of each periodic payment by APM to Company payable during the pendency of a Good Faith Allegation of Breach shall return to $2.25 Million. 

 

	4.	GENERAL PROVISIONS 

 Except as expressly set forth in this Amendment, each term and provision of the Prior Development Agreement shall remain in full force and effect. To the extent there is a conflict between this Second
Amendment and the Prior Development Agreement, the provisions of this Second Amendment shall control. 

  

VELOCE TECHNOLOGIES, INC. 

SECOND AMENDMENT TO DEVELOPMENT AGREEMENT 

3 

 *** Text Omitted and Filed Separately 

Confidential Treatment Requested 
 Under 17 C.F.R. §§ 200.80(b)(4) 
 and 240.24b-2 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

  

VELOCE TECHNOLOGIES, INC. 

SECOND AMENDMENT TO DEVELOPMENT AGREEMENT 

4 

 *** Text Omitted and Filed Separately 

Confidential Treatment Requested 
 Under 17 C.F.R. §§ 200.80(b)(4) 
 and 240.24b-2 

 

 IN WITNESS WHEREOF, the Parties have executed this
Agreement as of the Effective Date. 
  

									
	APPLIED MICRO CIRCUITS CORPORATION	 		 	VELOCE TECHNOLOGIES, INC.
					
	Signed: /s/	 	  
	 		 	Signed: /s/	 	  

	Name:	 	[...***...]	 		 	Name:	 	Balaji Baktha
	Title:	 	[...***...]	 		 	Title:	 	President and Chief Executive Officer
	Address:	 	215 Moffett Park Drive	 		 	Address:	 	20813 Stevens Creek Blvd., Suite 100
		 	Sunnyvale, CA 94089	 		 		 	Cupertino, CA 95014
	Fax No.:	 	(408) 542-8600	 		 	Fax No.:	 	(408) 351-0208

  

  

VELOCE TECHNOLOGIES, INC. 

SECOND AMENDMENT TO DEVELOPMENT AGREEMENT 

SIGNATURE PAGETechnology License Agreement

					
		  		  	 Exhibit 10.69
  

*** Text Omitted and Filed Separately
 Confidential Treatment Requested
 Under 17 C.F.R. §§
200.80(b)(4)
 and 240.24b-2

			
	          27 March, 2009	  	CONFIDENTIAL	  	LEC-TLA-00606-V6.0

  

 This Technology License Agreement (“TLA”) is made the 27th day of March,
2009 (“Effective Date”) 
 BETWEEN 
 ARM LIMITED whose registered office is situated at 110 Fulbourn Road, Cambridge CB1 9NJ, England (“ARM”); 
 and 
 APPLIED MICRO CIRCUITS CORPORATION whose principal place of business is situated at
215 Moffett Park Drive Sunnyvale CA 94089 (“AMCC”). 
 WHEREAS 
 LICENSEE has requested ARM and ARM has agreed to license to LICENSEE certain ARM Technology (defined below) on the following terms and conditions. 

 

	1.	Definitions 

  

	1.1	“ARM Compliant Product” means the relevant ARM Compliant Product as defined in each Annex 1. 

 

	1.2	“ARM Technology” means any or all, as the context admits, of the technology identified in each Annex 1 and any Updates thereto delivered by ARM to
LICENSEE. 

  

	1.3	“ASP” means the average sales price of an ARM Compliant Product in a Quarter, calculated by taking the figure for the aggregate of all invoices for the
distribution of such ARM Compliant Product in such Quarter by the entity exercising the licences to manufacture or have manufactured under this TLA (notwithstanding that such distribution may be between AMCC and a Subsidiary of AMCC or between
Subsidiaries of AMCC), less; (i) any value added, turnover, import or other tax, duty or tariff payable by law thereon; and (ii) any freight and insurance costs included in the invoiced price, and dividing it by the number of
units of such ARM Compliant Product accounted for under such invoices. 

  

	1.4	“Claim” means a written notice received by ARM and claiming infringement of the Intellectual Property of a third party by any of the ARM Technology and
which demands that ARM cease and desist from such claimed Intellectual Property infringement. 

  

	1.5	“Confidential Information” means; (i) the ARM Technology and derivatives thereof (including any translation, modification, compilation,
abridgement or other form in which the ARM Technology has been recast, transformed or adapted, but excluding silicon) and any trade secrets relating to the ARM Technology; (ii) any information designated in writing by either party, by
appropriate legend, as confidential; (iii) any information which if first disclosed orally is identified as confidential at the time of disclosure and is thereafter reduced to writing and sent to the other party within thirty
(30) days after its oral disclosure and designated, by appropriate legend, as confidential; and (iv) the terms and conditions of this TLA. 

 

	1.6	“Customer” means any entity that has contracted LICENSEE to design and manufacture integrated circuits for such entity. 

 

	1.7	“Designer” means, except as provided below, any entity sub-contracted by LICENSEE to provide design resource to LICENSEE for the development of an ARM
Compliant Product. Designer expressly excludes any entity that, at any time, enters into a contractual arrangement with the LICENSEE which places upon LICENSEE an obligation to either or both; (a) manufacture such ARM Compliant Product
for such entity; and (b) sell units of such ARM Compliant Product to such entity. 

  

	1.8	“Intellectual Property” means any patents, patent rights, trade marks, service marks, registered designs, topography or semiconductor mask work rights,
applications for any of the foregoing, copyright, unregistered design right and any other similar protected rights in any country and to the extent recognised by any relevant jurisdiction as intellectual property, trade secrets, know-how and
confidential information. 

  

					
	          NH/MG	 	1 of 19	 	ARM/AMCC

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	          27 March, 2009	  	CONFIDENTIAL	  	LEC-TLA-00606-V6.0

  

	1.9	“LICENSEE” means AMCC and each Subsidiary of AMCC. 

  

	1.10	“Manufacturer” means any entity sub-contracted by LICENSEE to manufacture integrated circuits for LICENSEE. 

 

	1.11	“Packaging House” means any entity sub-contracted by LICENSEE to package integrated circuits for LICENSEE. 

 

	1.12	“Quarter” means each calendar quarter ending the 31st March, 30th June, 30th September and 31st December of each year.

  

	1.13	“Subsidiary” means any company the majority of whose voting shares is now or hereafter owned or controlled, directly or indirectly, by a party hereto.
A company shall be a Subsidiary only for the period during which such control exists. For the purposes of this definition “control” shall mean beneficial ownership of more than 50% of the voting stock of such entity.

  

	1.14	“Term” means the term for which the subject ARM Technology is licensed to LICENSEE by ARM as specifically set out in Section 7 of the relevant
Annex 1. 

  

	1.15	“Test House” means any entity sub-contracted by LICENSEE to test integrated circuits for LICENSEE. 

 

	1.16	“Trade Marks” means the trade marks identified in Section 6 of each Annex 1. 

 

	1.17	“Trademark Guidelines” means the guidelines for the use of ARM’s Trade Marks as set out in Annex 2 and any amendment thereto delivered to LICENSEE
by ARM from time to time in accordance with the provisions of Clause 2.10. 

  

	1.18	“Updates” means any; (i) error corrections developed by or for ARM; and (ii) functional enhancements or other modifications
developed by or for ARM (which ARM in its discretion decides does not constitute a new product), together with any Intellectual Property embodied therein. 

 

	2.	License 

 ARM
Technology License 
  

	2.1	The ARM Technology shall be licensed to LICENSEE subject to the relevant license terms identified in Section 2 of the relevant Annex 1. 

Subcontracting Design 
  

	2.2	Subject to the provisions of Clause 3 (Confidentiality), LICENSEE may exercise the right, if granted in Section 2 of the relevant Annex 1, to have ARM Compliant
Products designed by any Designer, provided that; (i) LICENSEE does not grant to the Designer any license in respect of the ARM Technology for any other purpose; and (ii) LICENSEE ensures that each Designer;

  

	 	(a)	is subject to contractual obligations of confidentiality in respect of the ARM Confidential Information and ARM Technology which are in substantial accordance with the
provisions of Clause 3.3; 

  

	 	(b)	is subject to a contractual obligation to deliver the designs for the ARM Compliant Products solely to LICENSEE and not to use the designs for any other purpose; and

  

	 	(c)	is subject to a contractual obligation to return any ARM Confidential Information and ARM Technology to LICENSEE on the earlier of; (1) the completion of
the design; and (2) the end of the contractual confidentiality period (in the agreement between LICENSEE and Designer) for the relevant ARM Confidential Information or ARM Technology. 

If any Designer breaches the obligations imposed upon it pursuant to LICENSEE’s obligations under Clauses 2.2(ii)(a) to 2.2(ii)(b),
LICENSEE agrees that such breach shall be treated as a material breach of this TLA by LICENSEE which shall entitle ARM to terminate this TLA in accordance with the provisions of Clause 14.2 and

  

					
	          NH/MG	 	2 of 19	 	ARM/AMCC

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	          27 March, 2009	  	CONFIDENTIAL	  	LEC-TLA-00606-V6.0

  

 
LICENSEE shall hold ARM harmless from and keep ARM indemnified against all and any loss, liability, costs, damages, expenses (including the fees of lawyers and other professionals), suffered,
incurred or sustained as a result of or in relation to such breach. 
 Customer Collaboration 

 

	2.3	Subject to the provisions of Clause 3 (Confidentiality), LICENSEE may exercise the right, if granted in Section 2 of the relevant Annex 1, to have ARM Compliant
Products designed by any Customer provided that; (i) LICENSEE does not grant to the Customer any license in respect of the ARM Technology for any purpose other than for collaborating on the design of ARM Compliant Products with LICENSEE
and; (ii) LICENSEE ensures that each Customer; 

  

	 	(a)	is subject to contractual obligations of confidentiality in respect of the ARM Confidential Information and ARM Technology which are in substantial accordance with the
provisions of Clause 3.4; 

  

	 	(b)	is subject to a contractual obligation to deliver the designs for the ARM Compliant Products solely to LICENSEE and not to use the designs for any other purpose; and

  

	 	(c)	is subject to a contractual obligation to return any ARM Confidential Information and ARM Technology to LICENSEE on the earlier of; (1) the completion of
the design; and (2) the end of the contractual confidentiality period (in the agreement between LICENSEE and Customer) for the relevant ARM Confidential Information or ARM Technology. 

If any Customer breaches the obligations imposed upon it pursuant to LICENSEE’s obligations under Clauses 2.3(i)(a) to 2.3(i)(c),
LICENSEE agrees that such breach shall be treated as a material breach of this TLA by LICENSEE which shall entitle ARM to terminate this TLA in accordance with the provisions of Clause 14.2 and LICENSEE shall hold ARM harmless from and keep ARM
indemnified against all and any loss, liability, costs, damages, expenses (including the fees of lawyers and other professionals), suffered, incurred or sustained as a result of or in relation to such breach. 

Subcontracting Manufacture 
  

	2.4	Subject to the provisions of Clause 3 (Confidentiality), LICENSEE may exercise the right, if granted in Section 2 of the relevant Annex 1, to have ARM Compliant
Products manufactured by a Manufacturer provided that; (i) LICENSEE does not grant to the Manufacturer any license in respect of the ARM Technology for any purpose other than for manufacturing ARM Compliant Products solely for LICENSEE;
and (ii) LICENSEE ensures that each Manufacturer; 

  

	 	(a)	is subject to contractual obligations of confidentiality in respect of the ARM Confidential Information and ARM Technology which are in substantial accordance with the
provisions of Clause 3.2; 

  

	 	(b)	is subject to a contractual obligation to use the ARM Confidential Information and ARM Technology solely for the purpose of supplying units of the ARM Compliant
Products solely to LICENSEE; and 

  

	 	(c)	is subject to a contractual obligation to return any ARM Confidential Information and ARM Technology to LICENSEE on the earlier of; (1) the completion of
the manufacture; and (2) the end of the contractual confidentiality period (in the agreement between LICENSEE and Manufacturer) for the relevant ARM Confidential Information or ARM Technology. 

If any Manufacturer breaches the obligations imposed upon it pursuant to LICENSEE’s obligations under Clauses 2.4(ii)(a) to
2.4(ii)(b), LICENSEE agrees that such breach shall be treated as a material breach of this TLA by LICENSEE which shall entitle ARM to terminate this TLA in accordance with the provisions of Clause 14.2 and LICENSEE shall hold ARM harmless from and
keep ARM indemnified against all and any loss, liability, costs, damages, expenses (including the fees of lawyers and other professionals), suffered, incurred or sustained as a result of or in relation to such breach. 

Subcontracting Testing 
  

	2.5	Subject to the provisions of Clause 3 (Confidentiality), LICENSEE may exercise the right, if granted in Section 2 of the relevant Annex 1, to have tested ARM
Compliant Products by a Test House provided that; (i) LICENSEE does not grant to the Test House any license in respect of the ARM Technology for any purpose other than for testing ARM Compliant Products solely for LICENSEE; and
(ii) LICENSEE ensures that each Test House; 

  

					
	          NH/MG	 	3 of 19	 	ARM/AMCC

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	          27 March, 2009	  	CONFIDENTIAL	  	LEC-TLA-00606-V6.0

  

	 	(a)	is subject to contractual obligations of confidentiality in respect of the ARM Confidential Information and ARM Technology which are in substantial accordance with the
provisions of Clause 3.5; 

  

	 	(b)	is subject to a contractual obligation to use the ARM Confidential Information and ARM Technology solely for the purpose of supplying units of the tested ARM Compliant
Products solely to LICENSEE; and 

  

	 	(c)	is subject to a contractual obligation to return any ARM Confidential Information and ARM Technology to LICENSEE on the earlier of; (1) the completion of
the testing; and (2) the end of the contractual confidentiality period (in the agreement between LICENSEE and Test House) for the relevant ARM Confidential Information or ARM Technology. 

If any Test House breaches the obligations imposed upon it pursuant to LICENSEE’s obligations under Clauses 2.5(ii)(a) to 2.5(ii)(c),
LICENSEE agrees that such breach shall be treated as a material breach of this TLA by LICENSEE which shall entitle ARM to terminate this TLA in accordance with the provisions of Clause 14.2 and LICENSEE shall hold ARM harmless from and keep ARM
indemnified against all and any loss, liability, costs, damages, expenses (including the fees of lawyers and other professionals), suffered, incurred or sustained as a result of or in relation to such breach. 

 

	2.6	LICENSEE may exercise the right, if granted in Section 2 of the relevant Annex 1, to have ARM Compliant Products be tested and packaged by a Packaging House
provided that (i) LICENSEE does not grant to the Packaging House any license in respect of the ARM Technology for any purpose other than for packaging and testing ARM Compliant Products solely for LICENSEE; and (ii) LICENSEE
ensures that each Packaging House is subject to a contractual obligation to return any ARM Confidential Information and ARM Technology to LICENSEE on the completion of the packaging 

If any Packaging House breaches the obligations imposed upon it pursuant to LICENSEE’s obligations under Clause 2.6, LICENSEE agrees
to take all reasonable actions to cure such breach. If LICENSEE is unable to cure such breach within thirty (30) days, then LICENSEE shall terminate the right of such Packaging House to package and test ARM Compliant Products for LICENSEE and
shall ensure that the Packaging House returns to LICENSEE any ARM Compliant Products in the Packaging House’s possession. 

Intercompany Matters 
  

	2.7	Any breach of this TLA by a Subsidiary of AMCC shall entitle ARM to terminate this TLA in accordance with the provisions of Clause 14.2 as if AMCC were the party in
breach. Any termination of this TLA in accordance with the provisions of Clause 14.2 shall be effective in respect of AMCC and all Subsidiaries. 

 Any rights granted to any Subsidiary hereunder shall automatically terminate upon such Subsidiary ceasing to be a Subsidiary. 
 In the event that a Subsidiary is in breach of any of the terms of this TLA, AMCC shall hold harmless and indemnify ARM against all and any loss, liability, costs, damages, expenses (including the
reasonable fees of lawyers and other professionals) suffered, as a result of or in connection with such breach. 
 License
Restrictions 
  

	2.8	Except as specifically licensed in accordance with Clause 2.1, LICENSEE acquires no right, title or interest in any ARM Confidential Information, ARM Technology or any
Intellectual Property embodied therein. In no event shall the licenses granted in accordance with Clause 2.1 be construed as granting LICENSEE, expressly or by implication, estoppel or otherwise, a license to use any ARM technology except the ARM
Technology. 

 Except as expressly licensed in accordance with Clause 2.1, no right is granted to LICENSEE to
sublicense the rights granted to LICENSEE under this TLA. 
 Intellectual Property Notices 

 

	2.9	 LICENSEE shall reproduce and not remove or obscure any notice incorporated in the ARM Technology by ARM to protect ARM’s Intellectual Property or
to acknowledge the Intellectual Property of any third party. LICENSEE shall incorporate and shall require that any Designer, Customer, Manufacturer and Test House to which any ARM Technology is provided in accordance with the terms of this TLA,
incorporates corresponding notices and such other 

  

					
	          NH/MG	 	4 of 19	 	ARM/AMCC

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	          27 March, 2009	  	CONFIDENTIAL	  	LEC-TLA-00606-V6.0

  

 
markings and notifications as ARM may reasonably require on all copies of the ARM Technology and any derivatives thereof (including any translation, modification, compilation, abridgement or
other form in which the ARM Technology has been recast, transformed or adapted) created by LICENSEE, Designer, Customer, Manufacturer, Test House or Packaging House, as the case may be. 

ARM Trade Marks 
 2.10 ARM hereby grants to LICENSEE a non-transferable (subject to Clause 16.3), non-exclusive, royalty-free, world-wide license to use the Trade Marks in connection with the promotion and sale of products
developed under the licences granted in this TLA. 
 LICENSEE shall use the Trade Marks, in accordance with the Trademark
Guidelines. ARM shall have the right to revise the Trademark Guidelines and Section 6 of any Annex 1. Any such revisions shall be effective with respect to printed materials and products to be produced or manufactured after ninety
(90) days from receipt of ARM’s written notice specifying the revisions to LICENSEE. 
 Upon request from ARM, LICENSEE
shall submit samples of documentation, packaging, and promotional or advertising materials bearing the Trade Marks to ARM so that ARM may verify compliance with the Trademark Guidelines. In the event that any documentation, packaging, promotional or
advertising material fails to comply with the Trademark Guidelines, ARM shall notify LICENSEE and LICENSEE shall rectify such documentation, packaging, and promotional or advertising materials so as to comply with the Trademark Guidelines and cease
using any such non-compliant materials as soon as reasonably possible after the date of ARM’s notice. 
 LICENSEE agrees to
provide reasonable assistance to ARM in maintaining the validity of the Trade Marks. Upon ARM’s request, LICENSEE shall provide, free of charge, a reasonable number of samples of the use of the Trade Marks for the purpose of trademark
registration or renewal. Upon request, LICENSEE shall at ARM’s expense execute any documents required by the applicable laws of any jurisdiction for the purpose of either or both registering and maintaining the Trade Marks. 

Except as provided by the terms of this TLA, LICENSEE shall not use or register, in any jurisdiction, any trademark, service mark, device
or logo or any word or mark confusingly similar to any of the Trade Marks. 
  

	3.	Confidentiality 

Restricted Disclosure 
  

	3.1	Except as expressly provided by Clauses 3.2, 3.3, 3.4, 3.5, 3.6 and 3.7, each party shall maintain in confidence the Confidential Information disclosed by the other
party and apply security measures no less stringent than the measures that such party applies to its own like information, but not less than a reasonable degree of care, to prevent unauthorised disclosure and use of the Confidential Information. The
period of confidentiality shall be indefinite with respect to each party’s Confidential Information. 

Permitted Disclosure to Manufacturers 
  

	3.2	LICENSEE may disclose the (i) the ARM Technology marked “M” in any Annex 1 and any translation, modification, compilation, abridgement or other
form in which the ARM Technology marked “M” has been recast, transformed or adapted; (ii) any GDSII created by or for LICENSEE from the synthesizable RTL licensed under any Annex 1 ; and (iii) any masks created from
the GDSII by or for LICENSEE, to a Manufacturer pursuant to the exercise of any have manufactured rights (if granted in Section 2 of the relevant Annex 1) solely for the purposes of having ARM Compliant Products manufactured for LICENSEE by
such third party and under a non-disclosure agreement containing substantially similar terms to this Clause 3, except that the confidentiality period for each deliverable shall be, at a minimum, of five (5) years from the date of disclosure.

 Permitted Disclosure to Designers 

 

	3.3	LICENSEE may disclose the ARM Technology marked “D” in any Annex 1 and any translation, modification, compilation, abridgement or other form in which the ARM
Technology marked “D” has been recast, transformed or adapted, to a Designer pursuant to the exercise of the have designed rights (if granted in Section 2 of the relevant Annex 1) solely for the purposes of having ARM Compliant
Products designed for LICENSEE by such third party and under a non-disclosure agreement containing substantially similar terms to this Clause 3, including the confidentiality period for each deliverable determined in accordance with the provisions
of Clause 3.1. 

  

					
	          NH/MG	 	5 of 19	 	ARM/AMCC

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	 27 March, 2009
	  	CONFIDENTIAL	  	LEC-TLA-00606-V6.0

  

 Permitted Disclosure to Customers 

 

	3.4	LICENSEE may disclose the ARM Technology marked “CS” in any Annex 1 and any translation, modification, compilation, abridgement or other form in which the ARM
Technology marked “CS” has been recast, transformed or adapted to a Customer solely for the purposes of collaborating on the design of ARM Compliant Products for such third party and under a non-disclosure agreement containing
substantially similar terms to this Clause 3, including the confidentiality period for each deliverable determined in accordance with the provisions of Clause 3.1. 

Permitted Disclosure to Test Houses 
  

	3.5	LICENSEE may disclose (i) the ARM Technology marked “T” in any Annex 1 and any translation, modification, compilation, abridgement or other form
in which the ARM Technology marked “T” has been recast, transformed or adapted; and (ii) any ATPG test vectors created by or for LICENSEE from the Synthesizable RTL (defined in the relevant Annex 1), to a Test House
pursuant to the exercise of the have tested rights (if granted in Section 2 of the relevant Annex 1) solely for the purposes of having ARM Compliant Products tested for LICENSEE by such third party and under a non-disclosure agreement
containing substantially similar terms to this Clause 3, except that the confidentiality period for each deliverable shall be, at a minimum, five (5) years from the date of disclosure. 

 

	3.6	Other Permitted Disclosures 

 Either party may disclose Confidential Information received from the other party in the following circumstances; 
  

	 	(i)	disclosure to third parties to the extent that the Confidential Information is required to be disclosed pursuant to a court order or as otherwise required by law,
provided that the party required to make the disclosure promptly notifies the other party upon learning of such requirement and has given the other party a reasonable opportunity to contest or limit the scope of such required disclosure (including
but not limited to making an application for a protective order); 

  

	 	(ii)	disclosure to nominated third parties under written authority from the original discloser of the Confidential Information; and 

 

	 	(iii)	disclosure to the receiving party’s legal counsel, accountants or professional advisors to the extent necessary for them to advise upon the interpretation or
enforcement of this TLA. 

 Permitted Disclosure of LICENSEE Confidential Information 

 

	3.7	LICENSEE royalty reports may be disclosed in confidence to ARM’s financial and legal advisors provided such advisors are bound by confidentiality restrictions
substantially as restrictive as those set forth herein. In addition, ARM may disclose the total unit sales, from time to time, of ARM Compliant Products provided that the unit sales of such products by LICENSEE are not separately identifiable or
deducible therefrom. 

 ARM shall be permitted to disclose LICENSEE Confidential Information to Subsidiaries of ARM
subject to the same terms and conditions of confidentiality as are set out in this TLA. 
 Restricted Use 

 

	3.8	LICENSEE agrees that it shall not use any of ARM’s Confidential Information other than pursuant to and in accordance with the exercise of any of the licences
granted under this TLA. Without limiting the generality of the foregoing, LICENSEE shall not use ARM’s Confidential Information; (i) for determining if any features, functions or processes provided by the ARM Technology or disclosed
by the ARM Confidential Information are covered by any patents or patent applications owned by LICENSEE; or (ii) for developing technology or products which avoid any of ARM’s Intellectual Property licensed hereunder; or
(iii) as a reference for modifying existing patents or patent applications or creating any continuation, continuation in part, or extension of existing patents or patent applications or (iv) for generating data for
publication or disclosure to third parties, which compares the performance or functionality of the ARM Technology with any other products created by LICENSEE or a third party, without obtaining ARM’s prior written consent.

 Excepted Information 
  

	3.9	The provisions of this Clause 3 shall not apply to information which; 

  

	 	(i)	is known to and has been reduced to tangible form by the receiving party prior to its receipt provided that such information is not already subject to any obligations
of confidentiality; or 

  

					
	 NH/MG
	 	6 of 19	 	ARM/AMCC

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	 27 March, 2009
	  	CONFIDENTIAL	  	LEC-ANX-00606-V6.0

  

	 	(ii)	is in the public domain at the time of receipt or later becomes part of the public domain without breach of the confidentiality obligations in this TLA; or

  

	 	(iii)	is received from a third party without any breach of any obligation of confidentiality in respect of such information provided that such information is not subject to
any continuing obligations of confidentiality; 

  

	 	(iv)	is identified as (N) in Section 1 of the relevant Annex 1 of this TLA; or 

 

	 	(v)	is independently developed without reference to ARM’s confidential information. 

 

	4.	Verification 

  

	4.1	Prior to the distribution of any integrated circuit incorporating ARM Technology manufactured by or for LICENSEE under the licenses granted in Section 2 of any
Annex 1, LICENSEE shall verify such ARM Technology to the extent required by and in accordance with the verification procedure set out in Section 3 of the relevant Annex 1. 

 

	5.	Delivery 

  

	5.1	ARM shall use reasonable efforts to deliver the ARM Technology in each Annex 1 to LICENSEE on or before the delivery dates set out in Section 1 of the relevant
Annex 1. Subject to the payment of the relevant Fees (defined in Clause 6.1), ARM shall deliver Updates for any ARM Technology to LICENSEE as soon as reasonably possible after such Update is made generally available by ARM. 

 

	6.	Fees and Royalties 

Fees 
  

	6.1	AMCC shall pay, to ARM, fees (“Fees”) as set out in and in accordance with Section 8 of the relevant Annex 1. 

Royalties 
  

	6.2	If provided for in Section 8 of a relevant Annex 1, AMCC shall pay, to ARM, a royalty (“Royalty”) in accordance with the provisions of such Annex
1. 

 Any distribution of ARM Compliant Products by LICENSEE shall, in the absence of evidence to the contrary,
be deemed to be distributed under the licences granted to LICENSEE under this TLA and LICENSEE shall pay Royalties to ARM accordingly. The burden of proof for rebutting the above presumption shall be on LICENSEE. 

Royalty Report 
  

	6.3	AMCC shall submit a report within thirty (30) days after the end of each Quarter, containing at least the information required by the form set out in
Section 8 of each Annex 1. 

 Fair Market Value 

 

	6.4	For all transactions LICENSEE shall ensure that such transactions are conducted so that the ASP of any ARM Compliant Product are not manipulated for the purpose of
reducing the Royalties payable to ARM under this TLA. The invoice price of any ARM Compliant Product shall be deemed to be the higher of the actual invoice price and what the invoice price of the ARM Compliant Product would have been if such ARM
Compliant Product had been sold stand alone to an independent customer at a fair open market value. 

 Records

  

	6.5	For the period of [...***...] from the date that each royalty report is delivered to ARM by AMCC, LICENSEE shall keep such records and books of account,
identifying and providing invoice details for ARM Compliant Products to derive the ASP for each ARM Compliant Product to demonstrate compliance with LICENSEE’s obligations under this Clause 6. 

  

					
	NH/MG	 	7 of 19	 	ARM/AMCC

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	 27 March, 2009
	  	CONFIDENTIAL	  	LEC-ANX-00606-V6.0

  

 Audit 

 

	6.6	ARM shall have the right for representatives of a firm of independent chartered accountants (“Auditors”), to make an examination and audit, by prior
appointment during normal business hours, of all records and accounts as may under recognised accounting practices contain information bearing upon; 

  

	 	(i)	the number of units of ARM Compliant Products and ARM Technology which have been distributed by LICENSEE under this TLA; 

 

	 	(ii)	the ASP and fair market value of any ARM Compliant Product which have been distributed by LICENSEE under this TLA; 

 

	 	(iii)	the amount of Royalties payable to ARM under this TLA; and 

  

	 	(iv)	any fees payable to ARM under this TLA. 

  

	 	(v)	any information necessary to substantiate and verify the data submitted to ARM by LICENSE in any Royalty report. 

The Auditors shall be permitted to provide, to ARM, information relating to Clauses 6.6(i)-(v), including but not limited to, information
relating to the systems operated by LICENSEE to capture and record such information. Any information obtained pursuant to any audit performed in accordance with the provisions of this Clause 6.6 and provided by the Auditors to ARM shall be treated
by ARM as LICENSEE Confidential Information. The Auditors’ conclusions shall (in the absence of clerical or manifest error) be final and binding on the parties. Such audit shall be at ARM’s expense unless; (a) it reveals a net
underpayment of Royalties or other fees of five per cent (5%) or more in any Quarter: or (b) LICENSEE has failed to provide the Auditors with all requested records and accounts containing information bearing upon the subject matter
set out in this Clause 6.6(i)-(v) within ten (10) working days of such request, in which event AMCC shall promptly reimburse ARM for the costs of such audit. AMCC shall make good any underpayment of royalties forthwith. If the audit
identifies that AMCC has made an overpayment, such overpayment will be credited to the next payment or payments of Royalties or fees to be made by AMCC. 
 Taxes 
  

	6.7	All sums stated under this TLA do not include taxes. All applicable taxes shall be payable by LICENSEE in accordance with relevant legislation in force at the relevant
tax point. Any income or other tax which LICENSEE is required by law to pay or withhold on behalf of ARM with respect to any Royalties or other fees payable to ARM under this TLA may be deducted from the amount of such Royalties or other fees
otherwise due, provided, however, that in regard to any such deduction, AMCC shall give to ARM such assistance as may be necessary to enable or assist ARM to claim exemption therefrom, or credit therefor, and shall upon request furnish to ARM such
certificates and other evidence of deduction and payment thereof as ARM may properly require. 

 Payment

  

	6.8	 AMCC shall pay all Royalties and Fees due to ARM under the terms of this TLA on or before the thirtieth (30th ) day after receipt of ARM’s invoice therefor (“Due
Date”). ARM shall send any invoice for payment to the address set out in Section 8 of the relevant Annex 1 and AMCC shall provide ARM with at least ten (10) working days notice of any change to such address.

  

	6.9	If any sum under this TLA is not paid by the Due Date (defined in Clause 6.8), then (without prejudice to ARM’s other rights and remedies), in addition to the
invoice amount, ARM reserves the right to charge interest on such sum on a day to day from the Due Date to the date of payment at the rate of, the lesser of one percent (1%) per month and the maximum amount permitted by law.

 No Right of Set Off 
  

	6.10	All sums properly due to ARM under this TLA shall be paid in full and LICENSEE shall not be entitled to assert against ARM any credit, set-off or counterclaim arising
under any Annex 1 in order to justify withholding payment of any sum properly due under any other Annex 1. Obligations under each Annex 1 shall be construed as divisible from obligations under any other Annex 1 for the purposes of interpreting this
Clause 6.10. 

  

					
	NH/MG	 	8 of 19	 	ARM/AMCC

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	 27 March, 2009
	  	CONFIDENTIAL	  	LEC-ANX-00606-V6.0

  

	7	Support and Maintenance 

  

	7.1	Subject to LICENSEE’s payment of the appropriate Fees (defined in Clause 6.1), ARM shall provide to LICENSEE, in respect of the relevant ARM Technology the
following support and maintenance for such ARM Technology (“Support and Maintenance”); 

  

	 	(i)	the use of commercially reasonable efforts to correct any defects in the ARM Technology which cause such technology not to operate in accordance with the functionality
described in the relevant datasheet or manual for such technology. If ARM determines that such defects are due to errors in such description ARM shall promptly issue corrections to the datasheet or manual and shall not be required to revise the ARM
Technology, provided that LICENSEE’s use of the ARM Technology by LICENSEE is not adversely affected thereby; 

  

	 	(ii)	all Updates to such ARM Technology; and 

  

	 	(iii)	subject to the provisions of Clauses 7.2 and 7.3, reasonable telephone, e-mail and written consultation about the operation and application of such ARM Technology.

  

	7.2	The services provided under Clause 7.1(iii) shall expressly exclude any information relating to the design of products incorporating ARM Technology. Consulting services
may be provided by ARM under the terms of a separate written agreement. Support supplied by ARM may not be used either; (i) as a substitute for training; or (ii) as additional engineering resource for LICENSEE projects.

  

	7.3	The services provided under Clause 7.1(iii) shall be provided from the relevant ARM support centre, and shall be limited in accordance with the provisions of
Section 4 of the relevant Annex 1. Notwithstanding the foregoing, in exceptional cases if ARM has been unable to resolve an issue relating to the ARM technology remotely from the support centre, ARM will use reasonable efforts to provide
support to LICENSEE, at LICENSEE’s premises, subject to LICENSEE meeting all reasonable traveling, accommodation and sustenance expenses thereby incurred. 

 

	7.4	If ARM delivers a revision of any ARM Technology licensed under any Annex 1, LICENSEE hereby agrees and acknowledges that ARM shall only be obligated to test that each
deliverable is compatible with the other deliverables comprising such revision, and ARM shall have no responsibility for testing that any or all of such deliverables are compatible with previously delivered versions of the ARM Technology.

  

	7.5	ARM shall only have an obligation to provide maintenance as described in Clause 7.1(i) and (ii) for the most recently delivered version of the relevant ARM
Technology and the version which the most recently delivered version replaced. ARM shall be under no obligation to provide maintenance as described in Clause 7.1(i) and (ii) in respect of any modifications (where permitted) to the ARM
Technology created by LICENSEE 

  

	7.6	Upon LICENSEE requesting ARM’s assistance pursuant to the provisions of Clause 7.1(i) or (iii), LICENSEE shall promptly provide to ARM such samples and technical
information as ARM may reasonably require and in a form specified by ARM to enable ARM to provide such assistance. 

  

	7.7	ARM’s obligation under this Clause 7 is limited expressly to the provision of Support and Maintenance to LICENSEE and ARM shall be under no obligation to provide
any support and maintenance to any Designer, Customer, Manufacturer, Test House or other third parties. 

  

	7.8	If LICENSEE elects not to renew Support and Maintenance for any ARM Technology and subsequently requests ARM to provide Support and Maintenance in respect of such ARM
Technology, in addition to the fees due for the new Support and Maintenance period, LICENSEE hereby agrees that ARM shall be entitled to charge LICENSEE an appropriate fee in respect of the period in which LICENSEE has not received maintenance as
described in Clause 7.1(i) and (ii). 

  

	8.	Blank 

  

	8.1	This section is intentionally blank. 

  

					
	NH/MG	 	9 of 19	 	ARM/AMCC

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	 27 March, 2009
	  	CONFIDENTIAL	  	LEC-ANX-00606-V6.0

  

	9.	Training 

  

	9.1	If provided for in Section 5 of a relevant Annex 1, ARM shall provide training in respect of the relevant ARM Technology in accordance with the provisions of
Section 5 of the relevant Annex 1. 

  

	10.	ARM Technology Functionality Warranties 

  

	10.1	EXCEPT AS EXPRESSLY PROVIDED IN THIS TLA, ARM PROVIDES NO WARRANTIES EXPRESS, IMPLIED OR STATUTORY, INCLUDING, WITHOUT LIMITATION, THE IMPLIED WARRANTIES OF
MERCHANTABILITY, SATISFACTORY QUALITY, NON INFRINGEMENT OR FITNESS FOR A PARTICULAR PURPOSE WITH RESPECT TO THE ARM TECHNOLOGY. 

  

	10.2	ARM warrants to LICENSEE that the ARM Technology will be consistent with allowing a competent semiconductor manufacturer to manufacture products which substantially
conform to the functionality described in the relevant specification delivered by ARM as part of the ARM Technology and identified in Section 1 of the relevant Annex 1. LICENSEE acknowledges that the process for converting the ARM Technology
delivered to LICENSEE in to silicon necessarily involves the introduction and use of technology not delivered by ARM and accordingly ARM’s liability and LICENSEE’s sole remedy for breach of the warranty provided under this Clause 10.2
shall be as follows; if LICENSEE can demonstrate to ARM that any defect that is manifested or would be manifested in the silicon of an ARM Compliant Product developed using any ARM Technology is exclusively caused by a defect in the ARM Technology
as delivered to LICENSEE then ARM shall use commercially reasonable efforts to either or both; (i) correct any errors in the ARM Technology and deliver the corrected ARM Technology to LICENSEE; or (ii) create a workaround to remedy the
defect and deliver such workaround to LICENSEE. THE FOREGOING STATES THE ENTIRE LIABILITY OF ARM WITH RESPECT TO breach of the warranty provided in this clause 10.2. 

 

	10.3	WITHOUT PREJUDICE TO THE GENERALITY OF CLAUSE 10.2, ARM SHALL NOT BE RESPONSIBLE FOR ANY RECOVERABLE OR NON-RECOVERABLE COSTS INCURRED, DIRECTLY OR INDIRECTLY, BY
LICENSEE IN THE DESIGN MIGRATION, PROCESSING, OR MANUFACTURE OF MASKS AND PROTOTYPES, CHARACTERIZATION OR MANUFACTURE OF PRODUCTION QUALITY SILICON IN WHATEVER QUANTITY. 

 

	11.	ARM Technology Intellectual Property Warranties 

  

	11.1	ARM warrants, to ARM’s knowledge and belief, that; 

  

	 	(i)	the ARM Technology does not infringe any third party copyright, mask work right or trade secret; and 

 

	 	(ii)	as at the relevant Annex Effective Date, there are no pending; (a) Claims, or (b) actions commenced against ARM for infringement by the relevant
ARM Technology of any third party Intellectual Property. 

  

	11.2	LICENSEE’s exclusive remedy for any breach of the warranties provided in Clause 11.1 shall be the indemnification provided under Clause 12.1 of this TLA.

  

	12.	Intellectual Property Indemnities 

  

	12.1	Except as provided under Clause 12.2, in the event of a suit against LICENSEE based upon a claim that the Trade Marks or any of the ARM Technology delivered by ARM to
LICENSEE under this TLA and relevant Annex 1, when used in accordance with the provisions of this TLA and relevant Annex 1, infringes any third party Intellectual Property, ARM agrees, subject to the limitations of Clauses 13.1 and 13.2, to defend
and indemnify LICENSEE, at ARM’s expense, and to pay costs and damages finally awarded in any such suit or agreed in any settlement, provided that; (i) ARM is promptly notified by LICENSEE, in writing, of any threats, claims and
proceedings related thereto; (ii) ARM has sole control of the defence and any settlement thereof; (iii) LICENSEE does not make any admission of liability nor settle or otherwise compromise any such claim without ARM’s
prior written consent; (iv) LICENSEE furnishes to ARM, upon request, any information available to LICENSEE relating to the defense of such claim; (v) LICENSEE provides reasonable assistance to ARM in the defense of such
claim; and (vi) LICENSEE ceases use of the ARM Technology which is the subject of the infringement claim upon receipt from ARM of any non-infringing replacement for such ARM Technology. THE FOREGOING STATES THE ENTIRE LIABILITY OF ARM
WITH RESPECT TO INFRINGEMENT BY THE TRADE MARKS OR THE ARM TECHNOLOGY OF ANY THIRD PARTY INTELLECTUAL PROPERTY. 

  

					
	NH/MG	 	10 of 19	 	ARM/AMCC

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	27 March, 2009	  	CONFIDENTIAL	  	LEC-TLA-00606-V6.0

  

	12.2	ARM shall have no liability under Clause 12.1 in respect of; (i) any infringement arising from; (a) the combination of the ARM Technology with
other products not supplied by ARM if such infringement would not have occurred but for such combination; (b) any modification of the ARM Technology by or for LICENSEE if such infringement would not have occurred but for such
modification; (c) the process of synthesizing any ARM Technology including but not limited to the use by LICENSEE of LICENSEE’s or LICENSEE’s agent’s cell libraries if such infringement would not have occurred but for the
application of such process; or (d) any manufacturing process applied to the ARM Technology by LICENSEE if such infringement would not have occurred but for the application of such process; or (ii) any suit brought by a third
party against LICENSEE based upon a claim that any of the ARM Technology delivered by ARM to LICENSEE under this TLA infringes a patent owned by such third party where such claim has been made by such third party in response to an initial claim by
LICENSEE that such third party infringes any patent owned or controlled by LICENSEE. 

  

	12.3	If either a third party alleges, or ARM has any concerns, that any ARM Technology infringes or may infringe the Intellectual Property of a third party, then without any
admission of liability, ARM at its option and expense may develop an Update to the relevant ARM Technology which in ARM’s opinion avoids such alleged infringement and upon receipt of such Update from ARM, LICENSEE shall: (i) in
respect of any new design or derivatives of any existing designs which have not been taped out, immediately cease use of the ARM Technology which the Update replaces; and (ii) in respect of any existing designs which have been taped out,
within nine (9) months of receipt of the Update, cease use of the ARM Technology which the Update replaces. 

  

	12.4	If a suit against ARM is based in whole or in part upon a claim that any of the ARM Technology delivered by ARM to LICENSEE under this TLA, when used in accordance with
this TLA, infringes any third party Intellectual Property because of; (i) the combination of the ARM Technology with other products not supplied by ARM if such infringement would not have occurred but for such combination;
(ii) the modification by LICENSEE of the ARM Technology if such infringement would not have occurred but for such modification; (iii) the process of synthesizing any ARM Technology including but not limited to the use by
LICENSEE of LICENSEE’s or LICENSEE’s agent’s cell libraries if such infringement would not have occurred but for the application of such process; or (iv) any manufacturing process applied to the ARM Technology by LICENSEE
if such infringement would not have occurred but for the application of such process, then LICENSEE agrees to indemnify ARM for any legal costs (including attorney’s fees) reasonably incurred by ARM in defending such suit provided that LICENSEE
is notified promptly in writing of the suit and that at LICENSEE’s request, LICENSEE is given control of and all requested reasonable assistance to defend such suit to the extent that such suit relates to any of (i) to (iv) above.

  

	12.5	ARM shall only be liable under Clause 12.1 for any damages awarded by a court, for infringement by the Trade Marks or any ARM Technology of the Intellectual Property of
a third party, up to the date upon which such court issues its judgment. ARM shall have no continuing liability under Clause 12.1 for any loss suffered by LICENSEE in respect of the same infringement after the date of such judgment.

  

	13.	Limitation of Liability 

  

	13.1	EXCEPT IN RESPECT OF ANY BREACH OF THE PROVISIONS OF CLAUSE 3 (CONFIDENTIALITY), IN NO EVENT SHALL EITHER PARTY BE LIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL OR
CONSEQUENTIAL DAMAGES WHETHER SUCH DAMAGES ARE ALLEGED AS A RESULT OF TORTIOUS CONDUCT (INCLUDING NEGLIGENCE) OR BREACH OF CONTRACT OR OTHERWISE EVEN IF THE OTHER PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. 

 

	13.2	NOTWITHSTANDING ANYTHING TO THE CONTRARY CONTAINED IN THIS TLA, THE MAXIMUM LIABILITY OF ARM TO LICENSEE IN AGGREGATE FOR ALL CLAIMS MADE AGAINST ARM IN CONTRACT TORT
OR OTHERWISE UNDER OR IN CONNECTION WITH THE SUBJECT MATTER OF EACH ANNEX 1 SHALL NOT EXCEED ONE HUNDRED PERCENT (100%) OF THE FEES (DEFINED IN CLAUSE 6.1) PAID BY LICENSEE TO ARM UNDER SUCH ANNEX 1. THE EXISTENCE OF MORE THAN ONE CLAIM OR SUIT
WILL NOT ENLARGE OR EXTEND THE LIMIT. LICENSEE RELEASES ARM FROM ALL OBLIGATIONS, LIABILITY, CLAIMS OR DEMANDS IN EXCESS OF THIS LIMITATION. 

  

	13.3	NOTHING IN THIS CLAUSE SHALL OPERATE TO EXCLUDE LIABILITY FOR DEATH OR PERSONAL INJURY RESULTING FROM EITHER PARTY’S NEGLIGENCE. 

  

					
	NH/MG	 	11 of 19	 	ARM/AMCC

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	27 March, 2009	  	CONFIDENTIAL	  	LEC-TLA-00606-V6.0

  

	13.4	The parties hereby acknowledge that the provisions of this Clause 13 allocate the risks under this TLA between ARM and LICENSEE after negotiation and ARM’s pricing
reflects this allocation of risk and the limitation of liability specified herein. 

  

	14.	Term, Termination and Expiration 

 TLA Term 
  

	14.1	Except as provided below, this TLA shall commence on the Effective Date and shall continue in force unless earlier terminated in accordance with the provisions of
Clause 14.2. 

 Termination by Either Party 

 

	14.2	Without prejudice to any other right or remedy which may be available to it, either party shall be entitled immediately to terminate this TLA (including all Annexes
incorporated hereunder) by giving written notice to the other, if the other party: 

  

	 	(i)	has committed a material breach of any of its obligations hereunder which is not capable of remedy; or 

 

	 	(ii)	has committed a material breach of any of its obligations hereunder which is capable of remedy but which has not been remedied within a period of sixty (60) days
following receipt of written notice to do so; or 

  

	 	(iii)	any circumstances arise which would entitle the court or a creditor to appoint a receiver, administrative receiver or administrator or to present a winding-up petition
or make a winding-up order; or 

  

	 	(iv)	makes any voluntary arrangement with its creditors for the general settlement of its debts or becomes subject to an administration order; or 

 

	 	(v)	has an order made against it, or passes a resolution, for its winding-up (except for the purposes of amalgamation or reconstruction) or has a receiver or similar
officer appointed over all or substantially all of its property or assets. 

 Annex Expiry 

 

	14.3	Each Annex shall commence on the Annex Effective Date (defined in each Annex 1) and shall continue in force for the Term set out therein unless earlier terminated in
accordance with the provisions of Clause 14.2. 

  

	15.	Effect of Expiry and Termination 

 Termination by ARM 
  

	15.1	Upon termination of this TLA by ARM in accordance with Clause 14.2, LICENSEE will immediately discontinue any use and distribution of all ARM Technology, ARM
Confidential Information and any products embodying such technology or information. LICENSEE shall, at ARM’s option, either destroy or return to ARM any ARM Confidential Information, including any copies thereof in its possession and any ARM
Technology or derivatives (including any translation, modification, compilation, abridgement or other form in which the ARM Technology has been recast, transformed or adapted) thereof in its possession. Within one month after termination of this TLA
LICENSEE will furnish to ARM a certificate signed by a duly authorised representative of LICENSEE that to the best of his or her knowledge, information and belief, after due enquiry, LICENSEE has complied with provisions of this Clause.

 Upon termination of this TLA by ARM in accordance with either of Clauses 14.2; (i) the termination
date shall be treated as the end of a Quarter for the purpose of accounting for Royalties to ARM; and (ii) any fees outstanding, whether or not such fees have become due at the date of termination) shall become due and payable to ARM in
accordance with the provisions of Clause 6. 
 Termination by LICENSEE 

 

	15.2	Upon termination of this TLA by LICENSEE in accordance with Clause 14.2 the licenses granted under Clause 2 of this TLA shall survive such termination, subject to the
terms and conditions of this TLA including but not limited to LICENSEE’s continued payment, to ARM, its liquidator or receiver of any fees and Royalties due at the date of termination or in the future in accordance with the provisions of Clause
6. 

  

					
	NH/MG	 	12 of 19	 	ARM/AMCC

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	27 March, 2009	  	CONFIDENTIAL	  	LEC-TLA-00606-V6.0

  

 Annex 1 Expiry 

 

	15.3	Upon expiry of any Annex 1 in accordance with the provisions of Clause 14.3, 

 

	 	(i)	any licenses granted under Section 2 of the relevant Annex 1, [...***...]; 

 

	 	(ii)	any licenses granted under Section 2 of the relevant Annex 1, to manufacture, have manufactured and sell supply or otherwise distribute products developed using
the relevant ARM Technology shall survive subject to the terms and conditions of this TLA and subject to the continued payment to ARM of any fees and Royalties due at the time of expiry and in the future under the terms of this TLA and provided that
such products are already being distributed at the date of expiry of the Annex 1; and 

  

	 	(iii)	except as expressly provided to the contrary in this Clause 15.3(iii), LICENSEE shall at ARM’s option, either destroy or return to ARM any ARM Confidential
Information, including any copies thereof in its possession and any ARM Technology or derivatives (including any translation, modification, compilation, abridgement or other form in which the ARM Technology has been recast, transformed or adapted)
thereof in its possession but LICENSEE may keep one copy of the relevant ARM Technology for the purpose of supporting the products referred to in Clause 15.3(ii). 

 

	15.4	Upon termination the provisions of Clauses 1, 3, 6 (to the extent that any obligation under this Clause remains outstanding), 11, 13, 15 and 16 shall survive
termination. 

  

	16.	General 

  

	16.1	All communications between the parties including, but not limited to, notices, royalty reports, error or bug reports, the exercise of options, and support requests
shall be in the English language. 

  

	16.2	All notices which are required to be given hereunder shall be in writing and shall be sent to the address of the recipient set out below (either party may change their
respective address for service by giving notice of the change to the other party). Any such notice may be delivered personally, by commercial overnight courier or facsimile transmission which shall be followed by a hard copy and shall be deemed to
have been served if by hand when delivered, if by commercial overnight courier 48 hours after deposit with such courier, and if by facsimile transmission when dispatched. 

 

			
	 ARM Contact
	  	 LICENSEE Contact

	General Counsel	  	General Counsel
	110 Fulbourn Road	  	215 Moffett Park Drive
	Cambridge CB1 9NJ	  	Sunnyvale, CA 94089
	England	  	USA

  

	16.3	Neither party shall assign or otherwise transfer this TLA or any of its rights and obligations hereunder whether in whole or in part without the prior written consent
of the other, which consent shall not be unreasonably withheld. An assignment shall be deemed to include, without limitation; (i) any transaction or series of transactions whereby a third party acquires, directly or indirectly, the power
to control the management and policies of the party, whether through the acquisition of voting securities, by contract or otherwise; or (ii) the sale of more than fifty percent (50%) of the party’s assets whether in a single
transaction or series of transactions. 

  

	16.4	Neither party shall be liable for any failure or delay in its performance under this TLA due to causes, including, but not limited to, acts of God, acts of civil or
military authority, fires, epidemics, floods, earthquakes, riots, wars, sabotage, third party industrial disputes and governments actions, which are beyond its reasonable control; provided that the delayed party: (i) gives the other party
written notice of such cause promptly, and in any event within fourteen (14) days of discovery thereof; and (ii) uses its reasonable efforts to correct such failure or delay in its performance. The delayed party’s time for performance
or cure under this Clause 16.4 shall be extended for a period equal to the duration of the cause. 

  

					
	NH/MG	 	13 of 19	 	ARM/AMCC

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	27 March, 2009	  	CONFIDENTIAL	  	LEC-TLA-00606-V6.0

  

	16.5	ARM and LICENSEE are independent parties. Neither company nor their employees, consultants, contractors or agents are agents, employees or joint venturers of the other
party, nor do they have the authority to bind the other party by contract or otherwise to any obligation. Neither party will represent to the contrary, either expressly, implicitly, by appearance or otherwise. 

 

	16.6	Failure or delay by either party to enforce any provision of this TLA shall not be deemed a waiver of future enforcement of that or any other provision.

  

	16.7	The provisions contained in each clause and sub-clause of this TLA shall be enforceable independently of each of the others and if a provision of this TLA is, or
becomes, illegal, invalid or deemed unenforceable by any court or administrative body of competent jurisdiction it shall not affect the legality, validity or enforceability of any other provisions of this TLA. If any of these provisions is so held
to be illegal, invalid or unenforceable but would be legal, valid or enforceable if some part of the provision were deleted, the provision in question will apply with such modification as may be necessary to make it legal, valid or enforceable.

  

	16.8	This TLA, including all Annexes, constitutes the entire agreement between the parties with respect to the subject matter hereof, and supersedes and replaces all prior
or contemporaneous understandings or agreements, written or oral, regarding the subject matter. Except in respect of changes to the Trademark Guidelines which may be changed in accordance with the provisions of Clause 2.10, no amendment to or
modification of this TLA shall be binding unless in writing and signed by a duly Authorized representative of both parties. 

  

	16.9	The ARM Technology provided under this TLA is subject to U.S. export control laws, including the U.S. Export Administration Act and its associated regulations, and may
be subject to export or import regulations in other countries. LICENSEE agrees to comply fully with all laws and regulations of the United States and other countries (“Export Laws”) to assure that neither the ARM Technology, nor any
direct products thereof are; (i) exported, directly or indirectly, in violation of Export Laws, either to any countries that are subject to U.S export restrictions or to any end user who has been prohibited from participating in the U.S.
export transactions by any federal agency of the U.S. government; or (ii) intended to be used for any purpose prohibited by Export Laws, including, without limitation, nuclear, chemical, or biological weapons proliferation.

  

	16.10	The ARM Technology provided under this TLA consists solely of commercial items. LICENSEE shall be responsible for ensuring that any ARM Technology provided to the US
Government in accordance with the terms of this TLA is provided with the rights and restrictions described elsewhere herein. 

  

	16.11	Except as expressly stated in this TLA, the Contracts (Rights of Third Parties) Act 1999 and any legislation amending or replacing that Act shall not apply in relation
to this TLA or any agreement, arrangement, understanding, liability or obligation arising under or in connection with this TLA and nothing in this TLA shall confer on any third party the right to enforce any provision of this TLA.

  

	16.12	The validity, construction and performance of this TLA shall be governed by English Law. 

IN WITNESS WHEREOF the parties have caused this TLA to be executed by their duly authorised representatives: 

 

									
	 ARM LIMITED:
	 		 	APPLIED MICRO CIRCUITS CORPORATION:
					
	SIGNED:	 	 /s/
	 		 	SIGNED:	 	 /s/

	NAME:	 	Graham Budd	 		 	NAME:	 	[...***...]
	TITLE:	 	Chief Operating Officer	 		 	TITLE:	 	[...***...]
	DATE:	 	8 Apr 2009	 		 	DATE:	 	03-31-09

  

					
	NH/MG	 	14 of 19	 	ARM/AMCC

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	27 March, 2009	  	CONFIDENTIAL	  	LEC-TLA-00606-V6.0

  

 Annex 1 

  

					
	NH/MG	 	15 of 19	 	ARM/AMCC

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	27 March, 2009	  	CONFIDENTIAL	  	LEC-TLA-00606-V6.0

  

 Annex 2 
 Rules for Trademark Usage 
  

	1.	On Die Encapsulation 

  

	 	1.1	Except as set out in Clause 1.2, if Licensee is distributing ARM Compliant Products Licensee shall apply the Trademark identified in Section 6 Part A of
each Annex 1 to the die encapsulation (i.e. die package) of each unit of ARM Compliant Product. 

  

	 	1.2	Licensee shall not be obliged to apply the Trademark identified in Section 6 Part A of each Annex 1 to the die encapsulation of each unit of ARM Compliant
Product if; 

  

	 	1.2.1	Licensee provides written evidence to ARM that Licensee’s customer has requested that the die encapsulation of each unit of ARM Compliant Product is to bear no
trade marks whatsoever; or 

  

	 	1.2.2	Licensee provides written evidence to ARM that Licensee’s customer has requested that the die encapsulation of each unit of ARM Compliant Product is to bear only
the trademark of such customer; or 

  

	 	1.2.3	the size of the die encapsulation physically prohibits the application of both Licensee’s trademark and the Trademark identified in Section 6 Part A of each
Annex 1 when such marks are scaled to occupy the same area. 

  

	1.3	Where Licensee distributes ARM Compliant Products to an Intermediary, the packaging of each unit of such ARM Compliant Product so distributed must bear a mark which
unambiguously identifies Licensee as the manufacturing source of the ARM Product. If the packaging of the ARM Compliant Product cannot accommodate Licensee’s mark because of size limitations, then Licensee shall include a prominent statement
indicating that Licensee is the manufacturing source of the ARM Compliant Product (e.g. “Manufactured by [Licensee identity] under licence from ARM Limited”) in substantially all advertising material and promotional, technical or other
documentation, including press releases, associated with the ARM Compliant Product and Licensee shall oblige any Intermediary to do the same. 

 Where; “Intermediary” means any third party to whom Licensee distributes an ARM product and who is not an End User and “End User” means any person or other legal entity
which licenses an ARM Compliant Product for its own personal use or for use in the ordinary course of its business but not for onward sale, distribution or sublicensing. 

 

	1.4	Except as agreed in writing by ARM, any application by Licensee of the Trademark identified in Section 6 Part A of each Annex 1 shall be in accordance with
the Logo Design Guide set out in Exhibit A of this Schedule. 

  

	2.	On Product Packaging, Documentation, Copy, and Websites 

  

	2.1	ARM Powered Logo (Exhibit B)  

  

	 	(a)	Licensee may apply the Trademark identified in Section 6 Part B of each Annex 1 in a prominent place, to any product packaging for End User products
containing an ARM Compliant Product distributed under licence from ARM. 

  

	 	(b)	Licensee may apply the Trademark identified in Section 6 Part B of each Annex 1 to any advertising or promotional material for, or relating to, any
End User product containing an ARM Compliant Product distributed under licence from ARM. 

  

	 	(c)	Licensee may apply the Trademark identified in Section 6 Part B of each Annex 1 to the page(s) of Licensee’s web site relating to any End User
product containing an ARM Compliant Product distributed under license from ARM. 

  

	2.2	ARM Corporate Signature (Exhibit C) 

  

	 	(a)	Licensee shall apply the Trademark identified in Section 6 Part C of each Annex 1 in a prominent place, to any technical documentation for, or
relating to, any ARM Compliant Product distributed under licence from ARM. 

  

					
	NH/MG	 	16 of 19	 	ARM/AMCC
		 		 	

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	          27 March, 2009	  	CONFIDENTIAL	  	LEC-TLA-00606-V6.0

  

	 	(b)	Licensee may apply the Trademark identified in Section 6 Part C of each Annex 1 to any advertising or promotional material for, or relating to, any
ARM technology or to the company, ARM Limited. 

  

	 	(c)	Licensee shall apply the Trademark identified in Section 6 Part C of each Annex 1 to the page(s) of Licensee’s web site relating to any ARM
Compliant Product distributed under license from ARM. 

  

	 	(d)	The Trademark identified in Section 6 Part C of each Annex 1 may only be used as a logo to identify ARM (including ARM Holdings plc, its operating company
ARM Limited, and the regional subsidiaries). 

  

	2.3	ARM Connect Community Partner Logo (Exhibit D) 

  

	 	(a)	Licensee may apply the Trademark identified in Section 6 Part D of each Annex 1 to any advertising or promotional material for, or relating to,
Licensee’s business relationship with ARM. 

  

	 	(b)	Licensee may apply the Trademark identified in Section 6 Part D of each Annex 1 in a prominent place, to any technical documentation for, or relating
to, any ARM Compliant Product distributed under licence from ARM. 

  

	2.4	Licensee may use either of the Trade Marks identified in Section 6 Part C or Part D of each Annex 1 to create a hyperlink between the primary page of
Licensee’s website and the primary page of ARM’s website. 

  

	2.5	Any use or application by Licensee of the Trade Marks identified in Section 6 Part B, Part C or Part D of each Annex 1 shall be in accordance with;
(i) the Logo Design Guide set out in Exhibit B, Exhibit C, or Exhibit D as relevant of this Schedule; and (ii) with guidelines set forth in Clause 3 of this Schedule and other accepted trademark use standards.

  

	2.6	The Trade Marks identified in Section 6 Part B, Part C and Part D of each Annex 1 may only be used as logos and may not be incorporated into a body
of text. 

  

	2.7	Other Trade Marks 

  

	 	(a)	Licensee shall apply the appropriate Trademark from those identified in Section 6 Part E of each Annex 1 to any advertising material or promotional,
technical or other documentation relating to any ARM Compliant Product containing such ARM technology distributed by Licensee under licence from ARM. 

  

	 	(b)	Licensee may apply the appropriate Trademark from those identified in Section 6 Part E of each Annex 1 to any product packaging of any product
containing such ARM technology and distributed by Licensee under licence from ARM. 

  

	 	(c)	Licensee shall apply the Trade Marks identified in Section 6 Part E of each Annex 1 to the page(s) of Licensee’s website relating to any ARM
Compliant Product distributed under licence from ARM. 

  

	 	(d)	Any use of the Trade Marks identified in Section 6 Part E of each Annex 1 by Licensee shall be in accordance with the guidelines set forth in Clause 3 of
this Schedule and other accepted trademark use standards. 

  

	3.	Use Guidelines 

  

	 	3.1	 Where any registered Trademark is applied to any product packaging, advertising material or promotional, technical or other documentation relating to
any product distributed under license from ARM, then for each prominent use and the first use in any text of any such mark the mark must appear with the symbol “®” at the upper right corner of the mark. 

  

	 	3.2	 Where any unregistered Trademark is applied to any product packaging, advertising material and promotional, technical or other documentation relating
to any product distributed under licence from ARM, then for each prominent use and the first use in any text of any such mark the mark must appear with the symbol “TM“ at the upper right corner of the mark. 

  

	 	3.3	Licensee shall not adopt, use, or attempt to register any trademark which is confusingly similar to any ARM trademark 

  

					
	          NH/MG	 	17 of 19	 	ARM/AMCC

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	27 March, 2009	  	CONFIDENTIAL	  	LEC-TLA-00606-V6.0

  

	3.4	Licensee shall use trade marks only in the form in which they have been registered or are being claimed. To maintain the integrity of a trademark, Licensee shall never
use it in a possessive, plural, hyphenated, or abbreviated form; never alter it by adding letters or numbers or incorporating it into another word; always use the proper spelling, punctuation, capitalization, and font type. 

 

	3.5	Licensee shall never alter a Trademark 

 Correct: Use an ARM® PrimeCell® peripheral. 
 Incorrect: Add a PrimeCell® peripheral to your ARMory.

  

	3.6	Licensee shall use proper capitalization for a Trademark 

 Correct: ARM®  

Incorrect: Arm®  
  

	3.7	Licensee shall always use the appropriate descriptive generic noun written in lowercase letters after a Trademark 

Correct: ARM® core 

Incorrect: ARM® Core 
  

	3.8	 Licensee shall use a Registered Trademark Symbol (®) when Using “ARM” as a Trademark or Brand Name, but Not as a Trade Name 

Correct: ARM announces its new line of ARM® developer tools. 

Incorrect: ARM® Corporation. 
  

	3.9	Licensee shall include appropriate notices in substantially the following form on any product packaging, advertising material and promotional, technical or other
documentation relating to any product distributed under licence from ARM if such material contains an ARM Trademark; 

 For registered Trade Marks: “[Cite Trademark(s)] is [are] the registered trademark(s) of ARM Limited in the EU and other countries. 

For unregistered Trade Marks: “[Cite Trademark(s)] is [are] the trademark(s) of ARM Limited in the EU and other countries.

  

	3.10	Licensee shall always use the appropriate symbols with a trademark in a heading, as well as on the first occurrence of the trademark in a text. The same standards apply
to attributing trade marks on a Web page. Since each Web page has the potential to be viewed individually, trademark symbols should be used on each page, even if part of a multipage section or site. Licensee shall attribute trade marks on the first
occurrence within sidebars, charts, tables, graphics, diagrams, marketing slides, banners, “Related information” links, and other links on a Web page, because these elements have greater potential to be read or placed independently.

  

	3.11	In addition to the rules set out above ARM may provide Licensees with additional instructions relating to the use of the Trade Marks from time to time which Licensee
shall follow in its future use of the Trade Marks. 

  

					
	NH/MG	 	18 of 19	 	ARM/AMCC
		 		 	

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	27 March, 2009	  	CONFIDENTIAL	  	LEC-TLA-00606-V6.0

  

 Logo Design Guide 

Exhibit A 
  

 
 Exhibit B 
  

 
 Exhibit C 
  

 
 Exhibit D 
  

 
 The marks must appear exactly as shown in this Logo Design Guide; the elements, proportions and relationships must not
change. The marks are available in stat repro form and in .eps for Macintosh or .WMF for PC platforms. These formats ensure the highest possible reproduction quality. However, should you need another format for a specific project, please contact
your local ARM office for advice. 
 When produced in colour, the mark should be printed in Pantone 314 blue. Process colour reproduction may
not match Pantone-identified solid colour standards. When specifying the colour of the mark with process inks, the correct mix is: 
  

					
	 Cyan
	  	 	100	  
	 Magenta
	  	 	0	  
	 Yellow
	  	 	8.5	  
	 Black
	  	 	34	  

  

	•	 	 Do not alter or deform the shape of the marks. 

	•	 	 Do not replace the logotype with a different typeface or attempt to mimic the logotype typeface. 

	•	 	 Do not place competing visual elements (including but not limited to other Trade Marks) close to the marks. 

	•	 	 Do not set type near to the marks that could be construed as a corporate slogan or motto. 

  

					
	NH/MG	 	19 of 19	 	ARM/AMCC

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	30 June, 2010	  	Confidential	  	LEC-ANX-02052-V7.0

  

 ANNEX 1 
 AMCC 
 ARMV8-A ARCHITECTURE 

 
  
  

			
	 TLA Number
	  	[...***...]
	 Legal Counsel
	  	[...***...]
	 Annex Effective Date
	  	14 July 2010

 This Annex, when signed by both parties, shall form part of and be incorporated into the Technology Licence Agreement
(“TLA”) between the parties (document reference as identified in the table above). Solely for the purposes of interpretation of the TLA with respect to this Annex 1, to the extent that the provisions contained in this Annex 1
conflict with any of the provisions of the TLA the provisions contained in this Annex 1 shall prevail over and shall supersede the conflicting provisions in the TLA. Any change, deletion or amendment to this Annex 1 shall only be effective if agreed
upon in writing by the parties hereto. 

  

					
	AP/MH	 		 	ARM/AMCC
	Copyright © 2012, ARM Limited. All Rights Reserved	 	Page 1 of 18	 	

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	30 June, 2010	  	Confidential	  	LEC-ANX-02052-V7.0

  

 SECTION 1 – ARM TECHNOLOGY 
 Key to Disclosure Rights 
  

			
	[...***...]	  	[...***...]
	[...***...]	  	[...***...]
	[...***...]	  	[...***...]
	[...***...]	  	[...***...]
	[...***...]	  	[...***...]

 Key to Delivery Date Releases 
  

			
	[...***...]	  	[...***...]

 For the Documentation 
  

			
	[...***...]	  	[...***...]
	[...***...]	  	[...***...]
	[...***...]	  	[...***...]

 For the AVS 
  

			
	[...***...]	  	[...***...]
	[...***...]	  	[...***...]

  

					
	AP/MH	 		 	ARM/AMCC
	Copyright © 2012, ARM Limited. All Rights Reserved	 	Page 2 of 18	 	

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	30 June, 2010	  	Confidential	  	LEC-ANX-02052-V7.0

  

			
	[...***...]	  	[...***...]

 Subsection 1 – [...***...] Deliverables 
 PART A TECHNICAL REFERENCE DOCUMENTS 
  

							
	 Part Number
	  	 Description
	  	 Disclosure Rights
	  	 Delivery Date

	 [...***...]
	  	[...***...]	  	[...***...]	  	[...***...]
	 [...***...]
	  	[...***...]	  	[...***...]	  
	 [...***...]
	  	[...***...]	  	[...***...]	  

 PART B ARCHITECTURE VALIDATION 
  

							
	 Part Number
	  	 Description
	  	 Disclosure Rights
	  	 Delivery Date

	 [...***...]
	  	[...***...]	  	[...***...]	  	[...***...]

 Subsection 2 – [...***...] Deliverables 
 PART A – TECHNICAL REFERENCE DOCUMENTS 
  

							
	 Part Number
	  	 Description
	  	 Disclosure Rights
	  	 Delivery Date

	 [...***...]
	  	[...***...]	  	[...***...]	  	[...***...]
	 [...***...]
	  	[...***...]	  	[...***...]	  

  

					
	AP/MH	 		 	ARM/AMCC
	Copyright © 2012, ARM Limited. All Rights Reserved	 	Page 3 of 18	 	

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	30 June, 2010	  	Confidential	  	LEC-ANX-02052-V7.0

  

							
	 [...***...]
	  	[...***...]	  	[...***...]	  	
	 [...***...]
	  	[...***...]	  	[...***...]	  

 SECTION 2 - LICENCE AND SPECIAL CONDITIONS 

 

	A.	Definitions 

  

	A.1	[...***...] 

  

	A.6	“Architecture Compliant Core” [...***...] 

  

	A.7	“Architecture Reference Manuals” means [...***...] 

 

	A.8	“ARM Architecture” means [...***...]. 

  

	A.9	“ARM Compliant Product” means [...***...]. 

  

	A.10	[...***...]” means . [...***...]. 

  

	A.11	“ARM Instruction Sets” means [...***...]. 

  

	A.12	“ARM Intellectual Property” means; (i) any Intellectual Property in the ARM Technology owned or controlled by ARM and (ii) any
Necessary Claims in patents owned or controlled by ARM. 

  

	A.13	“ARM Licensee” means any party, together with any affiliates of such party, that has entered into a written agreement with ARM under which ARM grants
such party certain rights to products developed by or for ARM. 

  

	A.14	“ARM Technology” means [...***...]. 

  

	A.15	[...***...]. 

  

	A.16	[...***...]. 

  

	A.19	“ASIC” means an application-specific integrated circuit customized for a particular use, rather than intended for general-purpose use.

  

	A.20	“Assert” or “Assertion” means to bring an action of any nature before any legal, judicial, arbitral, administrative, executive or other type
of body or tribunal that has, or claims to have, authority to adjudicate such action in whole or in part. 

  

	A.21	[...***...] 

  

	A.22	[...***...] 

  

	A.24	“Designer” means (i) Veloce Technologies, Inc., located at 20813 Stevens Creek Blvd., Suite 100, Cupertino, CA 95014, an entity sub-contracted by
LICENSEE to provide design resource exclusively to LICENSEE; [...***...] 

  

	A.25	[...***...] 

  

	A.26	“Documentation” means the Architecture Reference Manuals and any ARM documentation referenced in the documentation identified in Section 1
Subsection 1 Part A and Section 1 Subsection 2 Part A. 

  

	A.27	[...***...] 

  

					
	AP/MH	 		 	ARM/AMCC
	Copyright © 2012, ARM Limited. All Rights Reserved	 	Page 4 of 18	 	

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	30 June, 2010	  	Confidential	  	LEC-ANX-02052-V7.0

  

	A.35	“LICENSEE Patents” means all classes or types of patents, utility models and design patents (including without limitation, originals, divisions,
continuations, continuations-in-part, extensions or reissues thereof) and any equivalent rights that are owned or controlled by LICENSEE that have an earliest effective filing date prior to the date of the end of the period ending [...***...]

  

	A.36	“Necessary Claims” means those claims in any patent which, without the appropriate permission of the entity which owns or controls the patent, will be
[...***...]. 

  

	A.37	“Programmer’s Model” means the programmer’s model for the ARM Architecture as more fully described in the Architecture Reference Manuals.

  

	A.38	[...***...]. 

  

	B.	Licence and Licence Restrictions 

  

	B.1	Subject to the provisions of Clause 3 (Confidentiality) of the TLA and the provisions in this Section 2, ARM hereby grants, to LICENSEE, under the ARM Intellectual
Property, a non-transferable (subject to Clause 16.3 of the TLA), non-exclusive, world-wide licence for the Term solely in the Field of Use to; 

 ARMv8-A Architecture Compliant Core 
  

	 	(i)	use, copy and modify the Documentation for the purposes of [...***...] 

 

	 	(ii)	use, copy and modify the Documentation for [...***...] 

  

	 	(iii)	use and copy the AVS [...***...] 

  

	 	(iv)	use, copy and modify [...***...]; 

  

	 	(v)	manufacture and have manufactured [...***...]; 

  

	 	(vi)	test and have tested [...***...]; 

  

	 	(vii)	sell, supply and distribute [...***...]; and 

  

	 	(viii)	supply and distribute documentation for [...***...]. 

 License Restrictions 
  

	B.2	LICENSEE’s use of the ARMv7-A Architecture Deliverables under the licences granted in Clause B.1 above is [...***...] 

 

	C.	Non-Assert 

  

	C.1	LICENSEE hereby agrees that LICENSEE shall not Assert against ARM any Essential Claims with respect to any product developed by ARM, only to the extent that such
Essential Claims embody are embodied or taken into use in any Architecture Compliant Core developed by LICENSEE. 

  

	C.2	LICENSEE hereby agrees that LICENSEE shall not Assert against an ARM Licensee any Essential Claims with respect to any product developed or derived from technology for
which the ARM Licensee has obtained a valid licence from ARM only to the extent that such Essential Claims are embodied or taken into use in any Architecture Compliant Core developed by LICENSEE, provided that such ARM Licensee does not initiate a
claim against LICENSEE that LICENSEE infringes any patent under such ARM Licensee’s ownership or control. 

  

	C.3	LICENSEE hereby agrees that LICENSEE shall not Assert against any direct or indirect customer of an ARM Licensee any Essential Claims with respect to any product
developed or derived from technology for which the ARM Licensee has obtained a valid license from ARM and which such customer has obtained directly or indirectly from such ARM Licensee only to the extent that such Essential Claims are embodied or
taken into use in any Architecture Compliant Core developed by LICENSEE. 

  

					
	AP/MH	 		 	ARM/AMCC
	Copyright © 2012, ARM Limited. All Rights Reserved	 	Page 5 of 18	 	

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	30 June, 2010	  	Confidential	  	LEC-ANX-02052-V7.0

  

	D.	Included Technology 

  

	D.1	During Term, ARM shall provide notice to LICENSEE of the availability of any Included Technology as soon as reasonably possible after such technology is Released.

  

	D.2	In respect of any Included Technology Released by ARM, LICENSEE may submit a request (“Technology Request”) requiring ARM to deliver the relevant
Included Technology to LICENSEE. As soon as reasonably possible after receipt of the Technology Request the parties shall enter into an Annex 1 for the relevant Included Technology which shall be substantially similar (except for the deliverables
and any contractual provisions that ARM is obligated to incorporate by a third party), to this Annex 1, and ARM shall deliver to LICENSEE the Included Technology as set forth in Section 1 of the relevant Annex 1. 

 

	E.	Confidentiality 

 E.1 For the purposes of
this Annex 1, Clauses 3.2 and 3.5 of the TLA are hereby replaced in their entirety by the following: 
 Permitted Disclosure to Manufacturers

  

	3.2	LICENSEE may disclose the (i) the ARM Technology marked “M” in any Annex 1 and any translation, modification, compilation, abridgement or other
form in which the ARM Technology marked “M” has been recast, transformed or adapted; (ii) any GDSII created by or for LICENSEE from the ARM Technology licensed under this Annex 1; and (iii) any masks created from
the GDSII by or for LICENSEE, to a Manufacturer pursuant to the exercise of any have manufactured rights (if granted in Section 2 of the relevant Annex 1) solely for the purposes of having ARM Compliant Products manufactured for LICENSEE by
such third party and under a non-disclosure agreement containing substantially similar terms to this Clause 3, except that the confidentiality period for each deliverable shall be [...***...]. 

Permitted Disclosure to Test Houses 
  

	3.5	LICENSEE may disclose (i) the ARM Technology marked “T” in any Annex 1 and any translation, modification, compilation, abridgement or other form
in which the ARM Technology marked “T” has been recast, transformed or adapted; and (ii) any ATPG test vectors created by or for LICENSEE from the ARM Technology licensed under this Annex 1, to a Test House pursuant to
the exercise of the have tested rights (if granted in Section 2 of the relevant Annex 1) solely for the purposes of having ARM Compliant Products tested for LICENSEE by such third party and under a non-disclosure agreement containing
substantially similar terms to this Clause 3, except that the confidentiality period for each deliverable shall be, at a minimum, five (5) years from the date of disclosure. 

 

	F.	Functionality Warranty 

  

	F.1	For the purposes of this Annex 1, Clause 10.2 of the TLA is hereby replaced in its entirety by the following: 

 

	10.2	ARM warrants to LICENSEE that the ARM Technology will; (i) be sufficient to allow a person reasonably skilled in the art to design an Architecture Compliant
Core; and (ii) be documented in a manner consistent with applicable industry standards. 

  

					
	AP/MH	 		 	ARM/AMCC
	Copyright © 2012, ARM Limited. All Rights Reserved	 	Page 6 of 18	 	

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	30 June, 2010	  	Confidential	  	LEC-ANX-02052-V7.0

  

	G.	Intellectual Property Indemnities 

  

	G.1	For the purposes of this Annex 1, Clause 12.2 and Clause 12.4 of the TLA are hereby replaced in their entirety with the following: 

 

	12.2	ARM shall have no liability under Clause 12.1 for; (i) any design implementation by LICENSEE except to the extent that and only to the extent that such
implementation infringes Necessary Claims (as defined in this Annex 1); (ii) any infringement arising from the combination of the ARM Technology with other products not supplied by ARM if such infringement would not have occurred but for
such combination; (iii) any infringement arising from the modification by LICENSEE of the ARM Technology if such infringement would not have occurred but for such modification; (iv) any infringement arising from the process
of synthesizing any ARM Technology including but not limited to the use by LICENSEE of LICENSEE’s or LICENSEE’s agent’s cell libraries if such infringement would not have occurred but for the application of such process; or
(v) any infringement arising from any manufacturing process applied to the ARM Technology by LICENSEE if such infringement would not have occurred but for the application of such process; or (vi) any loss arising from any
suit brought by a third party against LICENSEE based upon a claim that any of the ARM Technology delivered by ARM to LICENSEE under this TLA infringes a patent owned by such third party where such claim has been made by such third party in response
to an initial claim by LICENSEE that such third party infringes any patent owned or controlled by LICENSEE. 

  

	12.4	If a suit against ARM is based in whole or in part upon a claim that any of the ARM Technology delivered by ARM to LICENSEE under this TLA, when used in accordance with
this TLA, infringes any third party Intellectual Property because of; (i) infringement (excluding infringement of any Necessary Claims) by a design implementation by LICENSEE; (ii) the combination of the ARM Technology with other products
not supplied by ARM if such infringement would not have occurred but for such combination; (iii) the modification by LICENSEE of the ARM Technology if such infringement would not have occurred but for such modification; (iv) the process of
synthesizing any ARM Technology including but not limited to the use by LICENSEE of LICENSEE’s or LICENSEE’s agent’s cell libraries if such infringement would not have occurred but for the application of such process; or (iv) any
manufacturing process applied to the ARM Technology by LICENSEE if such infringement would not have occurred but for the application of such process, then LICENSEE agrees, subject to the limitations of Clause 13.2(B), to defend and indemnify ARM, at
LICENSEE’s expense, and to pay costs and damages finally awarded in any such suit or agreed in any settlement, but only to the extent such suit relates to any of (i) to (iv) above, provided that; (i) LICENSEE is promptly notified
by ARM, in writing, of any threats, claims and proceedings related thereto; (ii) LICENSEE has sole control of the defence and any settlement thereof; (iii) ARM does not make any admission of liability nor settle or otherwise compromise any
such claim without LICENSEE’s prior written consent; (iv) ARM furnishes to LICENSEE, upon request, any information available to LICENSEE relating to the defense of such claim; and (v) ARM provides reasonable assistance to LICENSEE ARM
in the defense of such claim. AMCC shall have no liability under this Clause 12.4 in respect of any suit brought by a third party based in whole or in part upon a claim that any of the ARM Technology delivered by ARM to LICENSEE under this TLA
infringes a patent owned by such third party where such claim has been made by such third party in response to an initial claim by ARM that such third party infringes any patent owned or controlled by ARM. 

 

	H.	Limitation of Liability 

  

	H.1	For the purposes of this Annex 1, Clause 13.2 of the TLA is hereby replaced in its entirety with the following: 

 

	13.2	(A) NOTWITHSTANDING ANYTHING TO THE CONTRARY CONTAINED IN THIS TLA, THE MAXIMUM LIABILITY OF ARM TO LICENSEE IN AGGREGATE FOR ALL CLAIMS MADE AGAINST ARM IN CONTRACT
TORT OR OTHERWISE UNDER OR IN CONNECTION WITH THE SUBJECT MATTER OF THE ANNEX 1 FOR THE ARMV8-A ARCHITECTURE SHALL NOT EXCEED ONE-HUNDRED PERCENT (100%) OF THE FEES (DEFINED IN CLAUSE 6.1) PAID BY LICENSEE TO ARM UNDER SUCH ANNEX 1. THE
EXISTENCE OF MORE THAN ONE CLAIM OR SUIT WILL NOT ENLARGE OR EXTEND THE LIMIT. LICENSEE RELEASES ARM FROM ALL OBLIGATIONS, LIABILITY, CLAIMS OR DEMANDS IN EXCESS OF THIS LIMITATION. 

(B) NOTWITHSTANDING ANYTHING TO THE CONTRARY CONTAINED IN THIS TLA, THE MAXIMUM LIABILITY OF LICENSEE UNDER CLAUSE 12.4 OF THE TLA IN
CONNECTION WITH THE SUBJECT MATTER OF ANNEX 1 FOR THE ARMV8-A ARCHITECTURE SHALL NOT EXCEED [...***...] OF THE FEES (DEFINED IN CLAUSE 6.1) PAID BY LICENSEE TO ARM UNDER SUCH ANNEX 1. 

  

					
	AP/MH	 		 	ARM/AMCC
	Copyright © 2012, ARM Limited. All Rights Reserved	 	Page 7 of 18	 	

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	30 June, 2010	  	Confidential	  	LEC-ANX-02052-V7.0

  

	I.	Lead Partner Provisions 

  

	I.1	As at the Annex Effective Date, the ARM Technology is still in development and, as a lead partner, LICENSEE will have access to the Development Releases and will be
able to provide feedback on the ARM Technology and its proposed implementation at the micro-architecture level. LICENSEE recognises the importance to ARM of ARM being able to licence its products generally, and therefore agrees that:

 (i) until such ARM Technology is delivered to LICENSEE in Early Access Release form, ARM at its discretion can
reuse any suggestions, comments, feedback, ideas, or know-how (whether in oral or written form) provided to ARM in respect of the ARM Architecture (“Input”) in accordance with the licenses granted under [...***...]. 

(ii) once the ARM Technology is delivered to LICENSEE in Early Access Release form, the parties agree that any suggestions, comments,
feedback, ideas, or know-how provided to ARM by LICENSEE in respect of the ARM Architecture must first be summarized in writing (“Written Input”) and submitted by the LICENSEE’s technical contact identified below to ARM’s
technical contract identified below. Only Written Input submitted by LICENSEE to ARM shall be considered to be licensed to ARM in accordance with the licenses granted under [...***...]. 

 

			
	 ARM Technical Contact
	  	 LICENSEE Technical Contact

	 [...***...]
	  	[...***...]
	 [...***...]
	  	

  

	I.2	ARM agrees to deliver to LICENSEE the Development Releases to enable LICENSEE to begin early development of the Architecture Compliant Cores. [...***...]

  

	I.3	[...***...] 

  

	I.4	[...***...] 

  

	J.	Option to Modify Field of Use 

  

	J.1	[...***...] 

  

					
	AP/MH	 		 	ARM/AMCC
	Copyright © 2012, ARM Limited. All Rights Reserved	 	Page 8 of 18	 	

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	30 June, 2010	  	Confidential	  	LEC-ANX-02052-V7.0

  

 SECTION 3 VERIFICATION 

 

					
	 1.
	 	 Verification

		
	 1.1
	 	 [...***...]

			
		 	 1.1.1
	 	Formulation and Execution of a Test Plan
			
		 		 	[...***...]
		
		 	 AND

			
		 	 1.1.2
	 	Running the AVS
		 		 	 [...***...]

		 		 	 Pass

		 		 	 [...***...]

		 		 	 Fail

		 		 	 [...***...]

			
		 	 AND
	 	
			
		 	 1.1.3
	 	[...***...]
			
		 		 	 Pass

		 		 	 [...***...]

		 		 	 Fail

		 		 	 [...***...]

  

					
	AP/MH	 		 	ARM/AMCC
	Copyright © 2012, ARM Limited. All Rights Reserved	 	Page 9 of 18	 	

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	30 June, 2010	  	Confidential	  	LEC-ANX-02052-V7.0

  

 SECTION 4 – SUPPORT LIMITATION 

 

	4.1	Except as provided below, the maximum number of man hours that ARM shall be obligated to expend on any individual support case submitted to ARM by LICENSEE shall be
[...***...] 

	4.2	If ARM reasonably believes that [...***...] 

	4.3	If a support case results [...***...] 

	4.4	If ARM, at ARM’s discretion, determines that [...***...] 

	4.5	If ARM agrees to provide support at [...***...] 

	4.6	For the avoidance of doubt, ARM’s provision of the support and maintenance services described in Clause 7 of the TLA is solely in respect of the ARM Technology as
delivered to LICENSEE. ARM shall have no obligation to provide support and maintenance services in respect of any Architecture Compliant Cores or ARM Compliant Products developed by LICENSEE. 

  

					
	AP/MH	 		 	ARM/AMCC
	Copyright © 2012, ARM Limited. All Rights Reserved	 	Page 10 of 18	 	

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	30 June, 2010	  	Confidential	  	LEC-ANX-02052-V7.0

  

 SECTION 5 - TRAINING REQUIREMENT 
 Not applicable. 
 SECTION 6 - TRADEMARKS 

 

			
	 Trademark
	  	 Registered/
Unregistered

 Part A 

 

			
	 [...***...]
	  	[...***...]

Part B 
  

			
	 [...***...]
	  	[...***...]

Part C 
  

			
	 [...***...]
	  	 [...***...]

 Part D 
  

			
	 [...***...]
	  	[...***...]

Part E 
  

			
	 [...***...]
	  	[...***...]

 Part F 

			
	 [...***...]
	  	[...***...]

  

					
	AP/MH	 		 	ARM/AMCC
	Copyright © 2012, ARM Limited. All Rights Reserved	 	Page 11 of 18	 	

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	30 June, 2010	  	Confidential	  	LEC-ANX-02052-V7.0

  

 SECTION 7 - TERM 

 

	7.1	Unless terminated earlier in accordance with the provisions of Clause 14 of the TLA, or unless LICENSEE makes an election under Clause 7.3 below, this Annex 1 shall
continue in force for a period of five (5) years from the Annex Effective Date. 

  

	7.2	For the purposes of this Annex 1, Clause 15.3 of the TLA is hereby replaced in its entirety with the following 

Annex 1 Expiry 
  

	15.3	Upon expiry of this Annex 1 in accordance with the provisions of Clause 14.3 of the TLA, 

 [...***...] 
  

	7.3.	Option to Terminate 

  

	(i)	If prior to the delivery by ARM to LICENSEE of the Early Access Release deliverables identified in Section 1, ARM is subject to [...***...] (as
defined herein), LICENSEE shall [...***...] 

 For the purposes of this clause, [...***...]
means a transaction or series of related transactions [...***...] in which [...***...] more than [...***...]. 
  

	(ii)	Upon termination of this Annex 1 in accordance with Clause 7.3(i) above, all licenses granted under Section 2 of this Annex 1 shall cease and LICENSEE will
immediately discontinue any use and distribution of all ARM Technology and ARM Confidential Information delivered under this Annex 1and any cores or products embodying such technology or information. LICENSEE shall, at ARM’s option, either
destroy or return to ARM any such ARM Confidential Information, including any copies thereof in its possession and any such ARM Technology or derivatives (including any translation, modification, compilation, abridgement or other form in which the
ARM Technology has been recast, transformed or adapted) thereof in its possession. Within one month after termination of this Annex 1 LICENSEE will furnish to ARM a certificate signed by a duly authorised representative of LICENSEE that to the best
of his or her knowledge, information and belief, after due enquiry, LICENSEE has complied with provisions of this Clause. 

  

	7.4	Notwithstanding anything to the contrary in the TLA, upon termination or expiration of this Annex 1 or upon termination of the TLA by either party in accordance with
the provisions of Clause 14 of the TLA, the provisions of Section 2 Clause C of this Annex 1 and any licenses granted pursuant to Section 2 Clause I.1 prior to such termination or expiration shall survive. 

  

					
	AP/MH	 		 	ARM/AMCC
	Copyright © 2012, ARM Limited. All Rights Reserved	 	Page 12 of 18	 	

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	30 June, 2010	  	Confidential	  	LEC-ANX-02052-V7.0

  

 SECTION 8 - FEES AND ROYALTIES 
 Subsection 1 - Fees 
 Table A - License Fees 

 

									
	 Fee (Descriptor)
	 	US$	 	 
	 	 	Due	 	 	Payable	 	Due Date (Invoice Date)
	[...***...]	 	 	[	...***...] 	 	[...***...]	 	[...***...]
		 				 	[...***...]	 	[...***...]
		 				 	[...***...]	 	[...***...]
		 				 	[...***...]	 	[...***...]
		 				 	[...***...]	 	[...***...]
		 				 	[...***...]	 	[...***...]
	[...***...]	 	 	[	...***...] 	 	[...***...]	 	[...***...]

 Support and Maintenance Fees 
 In respect of each year of the Term, in addition to the Licence Fee, LICENSEE shall pay to ARM annually the support and maintenance fees set out in the table below: 

Table B – Support and Maintenance Fees 
  

					
	 Fee (Descriptor)
	 	Due (US$)	 	Due Date (Invoice Date)
	[...***...]	 	[...***...]	 	[...***...]
	[...***...]	 	[...***...]	 	[...***...]
	[...***...]	 	[...***...]	 	[...***...]
	[...***...]	 	[...***...]	 	[...***...]
	[...***...]	 	[...***...]	 	[...***...]

 In the event LICENSEE wishes to obtain support and maintenance services from ARM for Year 6, LICENSEE shall notify ARM
prior to the fifth anniversary of the Annex Effective Date and the parties shall negotiate in good faith the support and maintenance fee for Year 6, which shall not exceed US [...***...] . 

Subsection 2 - Royalties 
 Currency:             US Dollars 
 Due:                      [...***...] 

 

  

					
	AP/MH	 		 	ARM/AMCC
	Copyright © 2012, ARM Limited. All Rights Reserved	 	Page 13 of 18	 	

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	30 June, 2010	  	Confidential	  	LEC-ANX-02052-V7.0

  

			
	 Payable:
	  	In accordance with the provisions of Clause 6 of the TLA.
		
	Invoice Address:	  	 [...***...]
 Applied
Micro
 215, Moffett Park Drive

Sunnyvale, Ca 94089

 Calculation: 
 A. As partial consideration for the manufacturing licenses herein, for each unit of ARM Compliant Product distributed by LICENSEE, LICENSEE shall pay a Royalty calculated by multiplying the ASP for the
ARM Compliant Product by the Royalty Rate determined from the following table, subject to part B below : 
  

							
	 Cumulative Number of Units of ARM
Compliant Products distributed
by
LICENSEE
	  	 Royalty Rate

% of ASP

	  	 ARM Compliant Product
containing an
Architecture
Compliant Core [...***...]
	  	ARM Compliant Product
containing an Architecture
Compliant Core [...***...]	  	ARM Compliant Product
containing an Architecture
Compliant Core with [...***...]
	 [...***...]
	  	[...***...]	  	[...***...]	  	[...***...]
	 [...***...]
	  	[...***...]	  	[...***...]	  	[...***...]
	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]

  

	B.	[...***...] 

  

	C.	[...***...] 

 [...***...] 

 

	D.	Except as otherwise provided in part B above, [...***...] 

  

			
	 Core
	  	% of royalty payable
	 [...***...]
	  	[...***...]
	 [...***...]
	  	[...***...]
	 [...***...]
	  	[...***...]
	 [...***...]
	  	[...***...]
	 [...***...]
	  	[...***...]

 [...***...] 
 Example 1: 
 [...***...] 

  

					
	AP/MH	 		 	ARM/AMCC
	Copyright © 2012, ARM Limited. All Rights Reserved	 	Page 14 of 18	 	

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	30 June, 2010	  	Confidential	  	LEC-ANX-02052-V7.0

  

 Example 2: [...***...] 
 ROYALTY REPORT 
 Form of Royalty Report 

Send to:         The address for ARM set out in the TLA via first class mail and to
royaltyreports@arm.com via email. 
  

			
	LICENSEE
                                         
                                         
              
	
	 LICENSEE contact
                                         
                                         
 

	
	 Quarter for which report relates to
                                         
                   

 Table 1 
  

																			
	 Part Number
	  	Intended
Application	  	Number of
Units of ARM
Compliant
Product
distributed by
LICENSEE
in Quarter	  	Number
of cores in
each
ARM
Compliant
Product	  	ASP(US$)	 	  	Applicable
Royalty
Rate	 	 	Royalty Due	 
		  		  		  		  	$	XXX	  	  	 	X	% 	 	$	XXX	  
		  		  		  		  	$	XXX	  	  	 	X	% 	 	$	XXX	  

 Table 2 
  

																	
	 Part Number
	  	Intended
Application	  	Estimated
Number of
Units of ARM
Compliant
Product
distributed by
LICENSEE
in
Next Calendar
Quarter	  	ASP (US$)	 	  	Applicable
Royalty
Rate	 	 	Royalty Due	 
		  		  		  	$	XXX	  	  	 	X	% 	 	$	XXX	  
		  		  		  	$	XXX	  	  	 	X	% 	 	$	XXX	  

 The information provided in Table 2 shall be non-binding, supplied in good faith and treated as LICENSEE’s
Confidential Information. 

  

					
	AP/MH	 		 	ARM/AMCC
	Copyright © 2012, ARM Limited. All Rights Reserved	 	Page 15 of 18	 	

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	30 June, 2010	  	Confidential	  	LEC-ANX-02052-V7.0

  

 SECTION 9 - MARKETING 
 Except as expressly provided below, neither party shall engage in any marketing activity relating to the ARM Technology licensed under this Annex 1 or to the existence of this Annex 1, without the prior
written agreement of the other party. 
 Notwithstanding anything to the contrary contained in the TLA, [...***...] 

The parties shall mutually agree the timing, terms and method of issuance of a written announcement, which may be a press release, relating to the
technology licensed under this Annex 1 and the relationship of the parties. 
 All communications for the above marketing activities shall be
sent to the following contacts 
  

			
	 ARM Marketing Contact
	  	 LICENSEE Marketing Contact

	 Director of Corporate Communications
	  	[...***...]
	 CommsDirector@arm.com
	  	
	 110 Fulbourn Road
	  	
	 Cambridge
	  	
	 CB1 9NJ
	  	

 SECTION 10 - [...***...] PATENTS 

 

			
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]

  

					
	AP/MH	 		 	ARM/AMCC
	Copyright © 2012, ARM Limited. All Rights Reserved	 	Page 16 of 18	 	

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	30 June, 2010	  	Confidential	  	LEC-ANX-02052-V7.0

  

			
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]
		
	 [...***...]
	  	[...***...]

  

					
	AP/MH	 		 	ARM/AMCC
	Copyright © 2012, ARM Limited. All Rights Reserved	 	Page 17 of 18	 	

					
		  		  	 *** Text Omitted and Filed Separately

Confidential Treatment Requested
 Under 17 C.F.R. §§ 200.80(b)(4)
 and 240.24b-2

			
	30 June, 2010	  	Confidential	  	LEC-ANX-02052-V7.0

  

 IN WITNESS WHEREOF the parties have caused this Annex 1 to be signed by their duly authorised
representative: 
  

					
	ARM LIMITED	 		  	APPLIED MICRO CIRCUITS CORPORATION
			
	BY: /s/	 		  	BY: /s/
	NAME: Tudor Brown	 		  	NAME: [***]
	TITLE: President	 		  	TITLE: [***]
	DATE: 20.7.10	 		  	DATE: 07/09/10

  

					
	AP/MH	 		 	ARM/AMCC
	Copyright © 2012, ARM Limited. All Rights Reserved	 	Page 18 of 18

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00209-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00209-of-00352.parquet"}]]